Drug-induced neutropenia

DRUGADVERS_NEUTROPENIA

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D70.82# 1 out of 7 registries used, show all original rules.	3242
4. Check minimum number of events None	3242
5. Include endpoints None	3242
6. Filter based on genotype QC (FinnGen only)	2812

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF5

NAME	DRUGADVERS_NEUTROPENIA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D7082
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Drug-induced neutropenia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	12860	7872	4919
Only index persons	11777	7306	4471
Unadjusted period prevalence (%)
Whole population	0.19	0.23	0.14
Only index persons	0.23	0.27	0.17
Median age at first event (years)
Whole population	63.94	62.61	66.05
Only index persons	63.92	62.58	66.11

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2812	1793	1019
Unadjusted period prevalence (%)	0.58	0.64	0.47
Median age at first event (years)	63.15	60.81	67.27

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2896: Matched controls
28960

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

130

Kela drug reimbursment

Malignant tumour

5.9

323.3

693

1466

HAC20

NOMESCO Finland

Total mastectomy

8.2

308.1

448

634

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

13.5

307.7

644

602

Z51.5

ICD-10 Finland

Palliative care

6.8

307.7

763

1455

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

20.8

307.7

949

664

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

28.5

307.7

334

132

H02AB02

ATC

dexamethasone; systemic

20.4

307.7

1814

2201

N02AA05

ATC

oxycodone; systemic

5.3

307.7

1218

3466

A04AA01

ATC

ondansetron; systemic, rectal

8.6

307.7

915

1482

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

19.3

307.7

306

176

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

9.7

307.7

433

516

L03AA13

ATC

pegfilgrastim; parenteral

23.7

307.7

1066

694

A49.9

ICD-10 Finland

Bacterial infection, unspecified

15.5

307.7

1487

1847

ZX120

NOMESCO Finland

Intravenous

7.6

307.7

881

1570

XW000

NOMESCO Finland

Bone marrow biopsy

9.9

307.7

489

584

A04AA02

ATC

granisetron; systemic, transdermal

15.7

307.7

1095

1079

A04AD12

ATC

aprepitant; systemic

17.2

307.7

401

268

D70.89

ICD-10 Finland

Neutropenic splenomegaly

29.0

307.7

323

125

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

9.2

307.7

454

576

XX3DW

NOMESCO Finland

Time consuming IT work

5.3

307.7

827

2028

JN4AD

NOMESCO Finland

Body CT examination

6.6

307.7

1009

2181

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

18.5

307.7

747

534

TPX10

NOMESCO Finland

Implantation of vascular injection port

10.4

307.7

384

418

A04AA55

ATC

palonosetron, combinations; systemic

11.1

307.7

550

599

115

Kela drug reimbursment

Breast cancer

8.1

307.7

929

1602

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

23.3

307.7

275

130

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

8.9

307.7

442

577

A03FA01

ATC

metoclopramide; systemic, rectal

15.2

307.7

2139

4548

L03AA02

ATC

filgrastim; parenteral

19.8

307.7

621

394

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

9.9

307.7

634

801

D70.82

ICD-10 Finland

Drug-induced neutropenia

+∞

307.7

2896

WF049

NOMESCO Finland

Radiotherapy of metastasis

10.2

307.7

427

485

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

18.8

307.7

302

178

JN4BD

NOMESCO Finland

Extensive body CT

8.2

307.7

1007

1760

L03AA14

ATC

lipegfilgrastim; parenteral

23.6

307.7

473

238

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

20.6

307.7

517

303

R50.9

ICD-10 Finland

Fever, unspecified

7.7

307.7

1286

2725

WW500

NOMESCO Finland

Blood transfusion

18.1

307.7

715

515

WZC00

NOMESCO Finland

Treatment plan or consultation

4.1

301.1

1803

8277

HA1AA

NOMESCO Finland

X-ray mammography

5.4

293.9

693

1587

L02BG04

ATC

letrozole; oral

5.9

291.3

607

1243

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.7

287.0

626

1336

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

6.3

278.4

530

994

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.2

274.0

2099

11135

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

6.3

273.8

515

954

J01MA12

ATC

levofloxacin; systemic

4.1

272.5

1051

3518

JN6AD

NOMESCO Finland

CT of torso and neck

13.0

269.3

268

226

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

23.3

260.0

190

D69.5

ICD-10 Finland

Secondary thrombocytopenia

80.5

259.0

138

A41.9

ICD-10 Finland

Sepsis, unspecified

8.7

256.1

346

446

L02BA01

ATC

tamoxifen; oral

7.2

255.6

416

663

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

26.8

251.4

174

L01BC06

ATC

capecitabine; oral

7.5

248.7

387

587

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

13.3

244.7

238

193

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

15.3

235.8

211

148

ZX112

NOMESCO Finland

Subcutaneous

10.7

234.1

264

268

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

5.8

230.7

475

952

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

7.3

228.5

360

552

PJA12

NOMESCO Finland

Sentinel node biopsy

4.5

205.3

592

1568

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

5.8

195.1

391

760

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.0

187.2

1514

7661

ZX070

NOMESCO Finland

Intensity modified radiotherapy

10.7

186.7

209

WF003

NOMESCO Finland

Adjuvant radiotherapy

6.7

183.6

308

502

WZC30

NOMESCO Finland

Teaching

3.3

178.4

889

3391

C83.1

ICD-10 Finland

Mantle cell lymphoma

43.1

173.8

104

ZX080

NOMESCO Finland

Image guided radiotherapy

8.2

171.1

237

312

X76

ICPC

Malignant neoplasm breast female

8.3

170.5

232

299

WW300

NOMESCO Finland

Transfer of autologic stem cells

30.0

161.5

107

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.2

160.5

814

3114

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.8

160.0

399

933

B01AB10

ATC

tinzaparin; parenteral

3.6

159.6

635

2087

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

11.3

153.4

164

153

M04AA01

ATC

allopurinol; systemic

3.5

152.2

625

2092

NK6AN

NOMESCO Finland

Total body bone isotope imaging

7.2

151.6

236

354

L01CA04

ATC

vinorelbine; systemic

14.1

150.0

139

103

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

6.5

149.6

256

424

L02BG06

ATC

exemestane; oral

8.7

147.4

192

234

JN4CD

NOMESCO Finland

Very extensive body CT

5.9

144.5

274

502

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

16.9

142.9

120

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

9.0

142.5

180

211

1CD02, ,

NOMESCO Finland

12.4

141.5

142

120

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

4.7

140.7

355

835

C50.99

ICD-10 Finland

Breast, unspecified

6.0

139.2

258

462

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

7.3

138.4

211

309

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

8.0

137.6

193

257

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

11.1

134.3

145

137

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

10.9

133.9

146

140

YNB10

NOMESCO Finland

Collection of stem cells for transplant

63.3

133.7

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

8.4

131.7

176

221

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

26.1

131.0

128

Kela drug reimbursment

Cancers of female genital organs

8.0

129.9

181

239

L01CB01

ATC

etoposide; systemic

18.2

128.9

104

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.4

127.5

270

546

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

8.5

125.0

165

204

L02BA03

ATC

fulvestrant; parenteral

15.5

124.2

109

192

Kela drug reimbursment

Fulvestrant

19.8

123.7

D64.9

ICD-10 Finland

Anaemia, unspecified

3.4

122.3

525

1789

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

6.8

122.3

199

312

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.7

121.1

237

446

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

8.4

119.2

159

199

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.2

116.7

209

361

PJA10

NOMESCO Finland

Exploration of lymph nodes

10.2

116.5

133

136

B01AB05

ATC

enoxaparin; parenteral

2.5

116.0

1253

6873

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

115.3

628

2454

WF004

NOMESCO Finland

Palliative radiotherapy

7.3

113.7

172

249

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

7.4

112.4

167

237

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.5

111.8

985

4905

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.6

110.8

402

1226

M05BX04

ATC

denosumab; parenteral

3.8

110.7

373

1082

TGC00

NOMESCO Finland

Bronchial lavation

6.1

107.2

194

338

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

106.8

906

4417

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.6

106.6

396

1225

A79

ICPC

Malignancy NOS

7.9

106.2

148

195

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

5.5

105.5

215

419

TQW20

NOMESCO Finland

Tatoe

9.1

104.1

129

147

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

6.0

101.3

187

332

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

9.2

101.1

125

142

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

8.1

100.8

138

178

ZX108

NOMESCO Finland

Inhalation

13.7

100.1

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

9.1

99.7

124

142

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.4

99.4

265

646

J01MA14

ATC

moxifloxacin; systemic

3.3

99.3

437

1501

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

15.3

97.5

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

6.0

96.9

177

311

A02BC02

ATC

pantoprazole; systemic

2.6

95.7

2310

17380

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

26.0

94.9

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

5.6

93.8

186

353

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

7.2

92.7

141

205

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

22.8

91.8

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.0

91.3

277

743

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

8.7

90.8

117

140

HAB40

NOMESCO Finland

Wedge excision of mammary gland

3.7

90.7

315

928

C50

ICD-10 Finland

Malignant neoplasm of breast

5.4

90.1

186

366

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

19.4

89.4

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

88.9

373

1240

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

5.7

87.4

167

306

1501

Kela drug reimbursment

Palbociclib

13.3

87.2

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.7

86.6

212

482

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

8.3

85.6

114

142

H02AB06

ATC

prednisolone; systemic

2.1

84.8

1634

10928

ZX121

NOMESCO Finland

Central venous catheter

18.3

84.7

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

9.9

84.6

102

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

10.1

84.0

C82.1

ICD-10 Finland

Follicular lymphoma grade II

13.3

82.1

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

6.9

81.3

128

193

Z51.0

ICD-10 Finland

Radiotherapy session

7.4

80.3

118

165

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.6

79.5

278

821

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

25.5

78.6

Z31.5

ICD-10 Finland

Genetic counselling

3.7

77.9

266

773

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

6.4

77.5

132

216

N05AH02

ATC

clozapine; systemic

7.0

77.3

119

175

ED1AA

NOMESCO Finland

Mandibular X-ray examination

13.1

77.0

394

Kela drug reimbursment

Palbociclib

12.8

76.2

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

12.9

75.3

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

7.8

75.3

106

141

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

4.9

75.3

173

373

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

10.0

75.1

FM1FN

NOMESCO Finland

Heart function isotope examination

12.5

73.8

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

73.7

774

4044

B03XA02

ATC

darbepoetin alfa; parenteral

5.4

72.7

148

287

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.3

72.6

150

295

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

18.7

71.8

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

21.1

71.7

ZX090

NOMESCO Finland

Other technic of radiotherapy

4.7

71.7

171

380

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

5.3

71.5

149

295

N05AH03

ATC

olanzapine; systemic

3.3

71.3

289

936

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

8.5

70.9

111

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.4

70.5

267

829

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

11.1

70.5

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

27.1

70.1

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

69.7

412

1651

WF002

NOMESCO Finland

Radical radiotherapy

3.4

69.4

268

842

TPX15

NOMESCO Finland

Removal of vascular injection port

14.3

69.1

A06AH03

ATC

naloxegol; oral

6.6

68.7

112

175

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

9.3

68.3

C03CA01

ATC

furosemide; systemic

2.1

67.7

968

5667

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

12.0

67.1

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

65.8

537

2506

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

7.8

65.1

120

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

65.1

423

1774

TGD00

NOMESCO Finland

Needle biopsy of lung

12.9

65.0

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

13.9

64.8

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

5.8

64.0

119

212

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

21.2

63.8

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.1

62.7

177

448

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

8.8

62.6

L01XE33

ATC

[U] palbociclib

15.1

62.3

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

15.3

61.4

GD1AD

NOMESCO Finland

Thorax CT examination

3.0

61.4

305

1110

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

5.3

60.7

124

241

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

5.9

60.6

111

195

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

60.2

468

2130

B99

ICD-10 Finland

Other and unspecified infectious diseases

5.6

60.1

116

214

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

22.3

59.7

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

8.8

59.6

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

5.6

59.5

116

216

N05BA06

ATC

lorazepam; systemic, sublingual

3.3

59.3

237

759

1XC02, ,

NOMESCO Finland

9.5

59.0

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

8.2

59.0

TPH07

NOMESCO Finland

Cathetrisation of artery

2.4

58.5

442

1985

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

58.0

1659

12067

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

3.2

58.0

250

838

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

7.2

57.7

122

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

6.7

57.0

139

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

7.6

56.9

109

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.5

56.8

389

1667

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.7

56.8

107

193

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.2

56.5

242

808

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

7.0

56.5

128

1XC03, ,

NOMESCO Finland

14.9

56.3

A41.8

ICD-10 Finland

Other specified sepsis

5.3

56.2

115

224

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

5.0

55.9

123

255

AA1BD

NOMESCO Finland

Extensive CT of head and brain

4.5

55.8

141

328

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.0

54.8

162

424

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

11.1

54.7

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

14.6

54.5

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.9

54.5

272

991

L02BG03

ATC

anastrozole; oral

5.1

54.2

115

231

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

4.2

54.1

149

370

WW409

NOMESCO Finland

Other aferesis

19.4

53.7

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

8.7

53.4

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

53.3

1163

7710

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.6

53.2

350

1469

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

6.9

52.7

122

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

52.1

864

5236

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

5.5

51.4

100

186

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.6

51.2

178

521

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

4.9

51.1

115

243

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

16.2

50.4

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

5.5

49.9

180

N05CF01

ATC

zopiclone; oral

1.8

49.9

1037

6737

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.5

49.3

123

283

ZZF00

NOMESCO Finland

Graft of adipose tissue

7.6

49.3

JAL30

NOMESCO Finland

Omentectomy

6.0

48.6

146

L01EF01

ATC

palbociclib; oral

11.9

48.1

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

48.1

1318

9269

N02AA01

ATC

morphine; systemic, rectal

5.1

47.5

102

207

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

5.0

47.2

103

212

R50.8

ICD-10 Finland

Other specified fever

10.8

47.1

PJW99

NOMESCO Finland

Other operation on lymphatic system

10.6

46.5

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

46.3

451

2242

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.3

46.2

379

1754

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

11.1

46.0

127

Kela drug reimbursment

Transplant complication

5.4

45.9

172

163

Kela drug reimbursment

Abiraterone and enzalutamide

8.7

45.6

J01DB01

ATC

cefalexin; oral

2.1

45.5

2468

21147

D40.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Testis

13.2

45.2

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

14.3

45.1

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

6.0

44.7

134

HAE99

NOMESCO Finland

Other reconstruction of breast

7.0

44.5

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

5.4

44.5

166

J05AB11

ATC

valaciclovir; oral

2.1

44.4

529

2839

3AA13, ,

NOMESCO Finland

16.0

44.4

WX402

NOMESCO Finland

General anaesthesia

1.9

44.3

769

4689

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

7.2

44.1

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.1

44.1

122

304

L02BB04

ATC

enzalutamide; oral

8.4

43.7

ZX095

NOMESCO Finland

Combined chemoradiotherapy

8.2

43.6

KFC00

NOMESCO Finland

Unilateral orchiectomy

11.1

43.3

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.6

43.1

104

233

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

15.6

42.6

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

14.8

42.5

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

14.8

42.5

A06AD11

ATC

lactulose; oral

2.1

42.1

468

2443

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

11.8

42.1

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

3.7

41.8

134

371

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.8

41.6

133

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.9

41.5

196

JAL00

NOMESCO Finland

Biopsy of peritoneum

9.7

41.3

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.4

40.9

304

1345

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

6.2

40.5

116

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

8.3

40.2

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.3

40.0

336

1567

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

4.4

39.7

102

240

R11

ICD-10 Finland

Nausea and vomiting

2.3

39.2

312

1421

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

4.4

39.2

230

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

39.0

780

4936

212

Kela drug reimbursment

Gout

4.8

38.6

188

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

5.2

38.5

158

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.9

38.4

184

653

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.6

38.1

202

R18

ICD-10 Finland

Ascites

4.2

37.7

102

250

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

5.4

37.6

139

L01BC59

ATC

trifluridine, combinations; systemic

12.5

37.6

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

5.8

37.4

122

J94.8

ICD-10 Finland

Other specified pleural conditions

5.1

37.4

162

1515, ,

Kela drug reimbursment

14.3

37.4

3030

Kela drug reimbursment

Abemaciclib

14.3

37.4

N02BE01

ATC

paracetamol; systemic, rectal

2.4

37.4

2667

23969

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

2.9

37.2

180

642

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

36.9

445

2385

ZXE00

NOMESCO Finland

One hour or less

1.7

36.6

1154

8247

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.0

36.0

103

263

ZZR10

NOMESCO Finland

Flap of skin and muscle

6.1

35.9

106

SPAT1255

SPAT

Intravenous administration of medicine

2.5

35.7

248

1062

A07AA09

ATC

vancomycin; oral

4.9

35.6

165

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

5.4

35.6

135

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

10.4

35.1

WZC15, ,

NOMESCO Finland

5.8

35.1

112

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

8.7

34.9

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

6.6

34.9

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

10.7

34.9

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

6.7

34.9

XX1XN

NOMESCO Finland

Other isotope examination

6.0

34.8

106

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

7.5

34.8

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.3

34.5

210

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

7.9

34.5

C56

ICD-10 Finland

Malignant neoplasm of ovary

7.4

34.4

JAH00

NOMESCO Finland

Laparotomy

3.5

34.3

120

352

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

6.3

34.3

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

10.7

34.0

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

13.5

34.0

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.4

33.8

127

390

9673/3-C42.1

ICD-O-3

Mantle cell lymphoma of bone marrow

93.7

33.8

J01MA02

ATC

ciprofloxacin; systemic

1.6

33.7

1144

8283

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

11.4

33.6

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

33.3

890

6059

C20

ICD-10 Finland

Malignant neoplasm of rectum

6.9

33.1

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

8.4

33.0

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

2.9

33.0

157

555

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

6.5

32.9

XX2RW, ,

NOMESCO Finland

4.4

32.6

190

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.2

32.5

134

436

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

9.0

32.5

L04AA06

ATC

mycophenolic acid; systemic

4.0

32.3

234

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

7.2

32.2

A07AA02

ATC

nystatin; oral

2.5

32.2

212

885

XX1AD

NOMESCO Finland

Other CT-examination

6.3

32.2

SPAT1109

SPAT

Analgesia with portable analgesic pump

8.3

32.1

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.8

32.1

152

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

11.1

32.0

N05AD01

ATC

haloperidol; systemic

3.4

31.7

114

341

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

31.4

906

6274

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

4.3

31.2

188

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.8

31.2

254

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.7

30.7

266

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

7.4

30.5

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

5.0

30.5

135

H02AB09

ATC

hydrocortisone; systemic

3.5

30.5

105

305

R06AE07

ATC

cetirizine; oral

1.6

30.3

1300

9875

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.2

30.2

119

377

L02BX03

ATC

abiraterone; oral

7.6

29.7

L02AE03

ATC

goserelin; implant

5.1

29.7

123

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

5.4

29.7

112

ZXD05

NOMESCO Finland

Urgent procedure

1.6

29.6

849

5851

A40.8

ICD-10 Finland

Other streptococcal sepsis

5.5

29.6

105

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.4

29.4

219

966

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

4.1

29.4

197

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

3.1

29.2

128

432

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

9.3

29.2

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

5.2

29.0

118

L02AE02

ATC

leuprorelin; implant, parenteral

2.8

28.9

151

561

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

28.8

212

931

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

9.1

28.6

Z3231

NOMESCO Finland

Registered nurse

1.6

28.4

794

5426

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

6.0

28.2

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

6.8

28.0

Z2446

NOMESCO Finland

Social worker

2.4

27.9

210

931

HAB99

NOMESCO Finland

Other partial excision of mammary gland

3.2

27.9

112

359

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.7

27.8

154

590

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

8.1

27.8

R84

ICPC

Malignant neoplasm bronchus/lung

9.0

27.7

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

6.7

27.7

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

27.5

1193

9022

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.0

27.5

322

1699

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.8

27.3

231

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

7.7

27.2

352

Kela drug reimbursment

Abiraterone and enzalutamide

7.7

27.2

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

6.2

27.1

TJA10

NOMESCO Finland

Laparocentesis

9.8

26.8

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

5.3

26.7

104

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

5.0

26.7

119

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

28.0

26.7

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.6

26.6

153

598

ZY010

NOMESCO Finland

Hospital outpatient

2.5

26.4

169

695

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

8.8

26.3

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

7.2

26.3

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

6.2

26.3

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

5.3

26.1

A46

ICD-10 Finland

Erysipelas

1.8

26.1

447

2668

J05AB01

ATC

aciclovir; systemic

1.6

25.9

677

4534

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

9.8

25.9

ZX131

NOMESCO Finland

Intrathecal

262.9

25.7

3AA02, ,

NOMESCO Finland

94.3

25.7

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.8

25.6

213

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.9

25.6

195

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

5.0

25.6

112

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

7.9

25.5

WPA13

NOMESCO Finland

Palliative consultation

6.9

25.5

SPAT1088

SPAT

Blood transfusion

8.3

25.3

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

35.9

25.2

JAH01

NOMESCO Finland

Laparoscopy

2.5

24.9

159

653

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

24.9

526

3329

L04AD02

ATC

tacrolimus; systemic

5.2

24.8

100

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

8.1

24.8

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

24.7

262

1333

JFF10

NOMESCO Finland

Loop enterostomy

6.9

24.6

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

3.2

24.3

305

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

8.9

24.2

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

24.1

511

3233

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

24.1

219

1050

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

6.3

24.0

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

4.2

23.8

152

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

8.7

23.7

WW200

NOMESCO Finland

Immunization

3.1

23.5

101

337

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

6.7

23.4

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.8

23.4

120

442

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

23.3

176

780

188

Kela drug reimbursment

Psychosis requiring demanding treatment

5.0

23.2

102

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.2

23.2

303

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

3.4

23.1

253

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

4.6

23.1

118

B02.9

ICD-10 Finland

Zoster without complication

2.1

23.1

240

1211

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

54.5

23.1

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

4.3

23.1

143

WNF00

NOMESCO Finland

Infection source and contact determination

8.6

22.8

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

7.8

22.5

ZX100

NOMESCO Finland

Oral

4.1

22.5

150

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

6.1

22.5

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

6.2

22.4

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.8

22.3

116

430

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.2

22.2

290

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

4.6

22.2

118

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

6.5

22.2

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

6.9

22.1

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

22.1

151

641

E0000UV, ,

ATC

1.5

22.0

1181

9208

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

6.4

21.8

C83.00

ICD-10 Finland

Lymphocytic lymphoma

18.5

21.7

N05BA04

ATC

oxazepam; oral

1.5

21.6

752

5356

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

3.2

21.6

285

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.5

21.5

138

568

X77

ICPC

Malignant neopl genital female other

8.8

21.5

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

21.4

342

1992

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.4

21.2

153

665

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

9.0

21.2

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.0

21.1

315

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

6.2

21.1

B01AB04

ATC

dalteparin; parenteral

2.3

21.0

167

758

N04AA02

ATC

biperiden; systemic

3.5

20.9

210

390

Kela drug reimbursment

Ibrutinib

21.6

20.8

WPB10

NOMESCO Finland

Making a convalescent care decision

6.4

20.5

N02AX02

ATC

tramadol; systemic, rectal

1.5

20.5

1230

9755

TQB05

NOMESCO Finland

Puncture of skin of trunk

4.5

20.3

110

L04AX01

ATC

azathioprine; systemic

2.4

20.2

140

598

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

3.4

20.1

215

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

6.8

20.0

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

6.8

20.0

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.1

19.9

133

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

19.9

198

982

ZX050

NOMESCO Finland

Stereotactic radiotherapy

4.8

19.9

UJF32

NOMESCO Finland

Coloscopy

1.5

19.7

759

5507

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

19.7

416

2621

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

6.5

19.6

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

8.2

19.6

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

4.5

19.6

109

B72

ICPC

Hodgkin Lymphoma

29.1

19.6

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.9

19.5

335

5BA08, ,

NOMESCO Finland

6.0

19.5

ZZQ70

NOMESCO Finland

Free microvascular graft of lymph nodes

40.4

19.5

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.2

19.3

175

838

L01EF03

ATC

abemaciclib; oral

15.6

19.2

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

19.2

450

2910

SPAT1269

SPAT

Other puncture and/or drainage

5.9

19.2

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

7.2

19.1

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

5.1

19.0

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.5

19.0

120

491

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.4

18.9

109

2499

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.0

18.9

217

1134

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.8

18.9

152

JFB00

NOMESCO Finland

Partial resection of small intestine

3.6

18.7

176

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

70.3

18.7

GD6AD

NOMESCO Finland

CT of chest and neck

7.1

18.7

R4110

NOMESCO Finland

Physiotherapy

1.5

18.6

802

5940

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.9

18.6

316

A03

ICPC

Fever

1.6

18.5

462

3034

WVA20

NOMESCO Finland

Medicine administration

2.7

18.4

103

397

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

5.5

18.4

GEA00

NOMESCO Finland

Mediastinoscopy

7.5

18.2

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

6.0

18.2

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

4.7

18.2

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

5.3

18.0

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

33.1

18.0

D70.80

ICD-10 Finland

Agranulocytic angina

52.8

18.0

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

7.3

17.8

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

4.8

17.8

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

6.8

17.4

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

3.7

17.4

147

N05AF05

ATC

zuclopenthixol; systemic

4.7

17.3

X21

ICPC

Breast sympt/compl female other

2.9

17.2

296

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

4.9

17.1

PG1BD

NOMESCO Finland

Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft

50.3

17.0

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

7.6

17.0

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

16.9

172

861

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.1

16.8

220

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.4

16.7

175

HAD99

NOMESCO Finland

Other plastic operation on breast

4.9

16.6

AAA10

NOMESCO Finland

Biopsy through craniotomy

90.6

16.6

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

7.0

16.5

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

16.4

16.5

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.3

16.5

131

594

WW402

NOMESCO Finland

Leucoferesis

27.7

16.5

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

5.1

16.5

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

16.5

148

706

1512

Kela drug reimbursment

Ibrutinib

18.0

16.4

N63

ICD-10 Finland

Unspecified lump in breast

1.9

16.4

204

1095

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.4

16.4

D75

ICPC

Malignant neoplasm colon/rectum

4.4

16.4

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

4.7

16.3

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

16.3

204

1097

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

16.2

322

4986

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.6

16.2

375

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

3.7

16.2

140

YX9AW, ,

NOMESCO Finland

5.0

16.2

N03AX16

ATC

[U] pregabalin

1.5

16.2

649

4719

RS220, ,

NOMESCO Finland

3.7

16.1

136

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

7.1

16.1

RD211, ,

NOMESCO Finland

2.2

16.0

136

634

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

15.9

2014

17869

C10AA07

ATC

rosuvastatin; oral

0.7

15.9

583

7903

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

5.7

15.9

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

12.3

15.8

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

5.0

15.7

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

5.5

15.7

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

15.7

991

7829

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.2

15.6

188

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

2.4

15.5

109

469

SPAT1254

SPAT

Administration of medicine

1.6

15.5

374

2429

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

4.0

15.5

108

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.4

15.5

159

A05AA02

ATC

ursodeoxycholic acid; oral

3.3

15.5

184

B37.08

ICD-10 Finland

Other candidal stomatitis

4.1

15.4

104

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

6.5

15.4

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

6.5

15.4

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.3

15.3

170

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

6.7

15.3

R4190

NOMESCO Finland

Nutritional therapy

2.2

15.2

123

562

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

2.6

15.2

328

WF099

NOMESCO Finland

Other radiotherapy

4.9

15.2

N05AL05

ATC

amisulpride; oral

28.8

15.2

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

5.6

15.1

C62.12

ICD-10 Finland

Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma

45.2

15.1

L04AD01

ATC

ciclosporin; systemic

3.0

15.0

224

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

15.0

168

870

WVA30, ,

SPAT

1.9

15.0

205

1136

N06AX16

ATC

venlafaxine; oral

1.6

14.9

402

2679

N05AA01

ATC

chlorpromazine; systemic, rectal

3.7

14.8

130

D70

ICD-10 Finland

Agranulocytosis

57.0

14.8

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

4.9

14.7

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

6.1

14.7

L01BB05

ATC

fludarabine; systemic

21.1

14.6

K83.1

ICD-10 Finland

Obstruction of bile duct

3.4

14.6

160

SPAT1153

SPAT

Removal of sutures

1.4

14.6

871

6793

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

6.4

14.6

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

4.6

14.5

SPAT1263

SPAT

Sampling

1.4

14.5

1088

8818

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

14.4

118

542

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.7

14.4

123

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

15.4

14.4

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

4.2

14.4

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

14.4

350

2276

N05AX12

ATC

aripiprazole; systemic

2.3

14.2

105

463

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

6.4

14.1

P01AB01

ATC

metronidazole; oral, rectal

1.4

14.1

1108

9033

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

12.0

14.1

A04AA03

ATC

tropisetron; systemic

6.7

14.0

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

5.9

14.0

N17.8

ICD-10 Finland

Other acute renal failure

3.5

13.9

136

A28

ICPC

Limited function/disability NOS

1.5

13.8

475

3336

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.8

13.8

246

N05AN01

ATC

lithium; oral

2.7

13.7

287

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

6.5

13.6

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.7

13.6

276

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

5.1

13.6

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.0

13.6

P72

ICPC

Schizophrenia

2.9

13.6

226

K12.10

ICD-10 Finland

Stomatitis NOS

5.0

13.6

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

4.8

13.5

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

5.9

13.5

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

5.9

13.5

C90.0

ICD-10 Finland

Multiple myeloma

3.5

13.4

134

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

2.9

13.4

222

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

5.6

13.4

L01EL01

ATC

ibrutinib; oral

25.9

13.4

C81.7

ICD-10 Finland

Other classical Hodgkin lymphoma

21.2

13.3

AA1AD

NOMESCO Finland

CT of head and brain

1.4

13.3

783

6076

E83.50

ICD-10 Finland

Hypercalcemia

3.2

13.3

170

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

13.3

137

689

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

6.3

13.3

N05AA02

ATC

levomepromazine; systemic

2.2

13.2

112

522

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

5.8

13.2

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

5.1

13.2

J01FF01

ATC

clindamycin; systemic

1.4

12.8

725

5585

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

5.4

12.8

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

2.7

12.7

240

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

9.7

12.7

M25.5

ICD-10 Finland

Pain in joint

0.7

12.7

571

7521

HA1HA

NOMESCO Finland

Tomosynthesis mammography

4.0

12.6

NE1DG

NOMESCO Finland

Pelvic, hip and femur very extensive MRI examination with high intensity magnet

4.8

12.6

QBA00

NOMESCO Finland

Puncture of skin of trunk

6.0

12.6

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

4.6

12.6

9663/3-C77.9

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS

32.2

12.6

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

4.1

12.6

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.4

12.5

373

OAB43, ,

SPAT

0.7

12.5

362

5185

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

5.2

12.5

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

10.1

12.5

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

6.2

12.5

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

20.1

12.4

XX9CD

NOMESCO Finland

Very extensive complementary CT

20.1

12.4

A02BC01

ATC

omeprazole; systemic

1.4

12.4

706

5436

C10AX09

ATC

ezetimibe; oral

0.6

12.4

225

3585

SPAT1301

SPAT

No procedures

1.4

12.4

799

6283

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

4.6

12.4

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

12.3

123

612

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

5.8

12.3

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

10.5

12.2

369

Kela drug reimbursment

Regorafenib

9.7

12.2

L02AB02

ATC

medroxyprogesterone; systemic

4.3

12.2

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

6.0

12.1

C81.2

ICD-10 Finland

Mixed cellularity classical Hodgkin lymphoma

18.1

12.0

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

12.0

255

1602

B34.9

ICD-10 Finland

Viral infection, unspecified

2.5

12.0

319

F20.10

ICD-10 Finland

Raise schizophrenia continuously

5.7

11.9

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

4.3

11.9

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.2

11.9

140

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

4.8

11.9

D61.1

ICD-10 Finland

Drug-induced aplastic anaemia

46.9

11.9

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

11.8

425

3007

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

4.2

11.8

L01BC53

ATC

tegafur, combinations; systemic

14.7

11.8

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

3.4

11.8

126

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

9.7

11.7

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

11.6

142

759

9680/3-C16.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of stomach, NOS

65.2

11.6

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

5.3

11.5

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

4.2

11.5

HA1BA

NOMESCO Finland

Extensive X-ray mammography

4.3

11.5

KBV00

NOMESCO Finland

Insertion of stent into ureter

4.3

11.5

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

11.5

170

966

QBJ00

NOMESCO Finland

Liposuction in trunk

4.4

11.4

C83.71

ICD-10 Finland

Burkitt's tumour

120.5

11.4

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

4.8

11.4

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

11.4

136

721

WF001

NOMESCO Finland

Preoperative radiotherapy

3.7

11.4

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.4

11.4

119

TJF80

NOMESCO Finland

Ostomy education

3.4

11.4

119

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

11.4

302

2002

N05AH04

ATC

quetiapine; oral

1.5

11.4

437

3132

A02BC05

ATC

esomeprazole; systemic

1.3

11.3

1101

9184

1CD01, ,

NOMESCO Finland

8.3

11.3

TGA30

NOMESCO Finland

Thoracocentesis

4.2

11.3

L01AA02

ATC

chlorambucil; oral

10.6

11.2

N03AX14

ATC

levetiracetam; systemic

2.3

11.2

373

C83.89

ICD-10 Finland

Other types of diffuse non-Hodgkin's lymphoma

25.1

11.1

L01XE27

ATC

[U] ibrutinib

20.1

11.1

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

5.3

11.1

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

11.0

211

1290

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

11.0

227

1415

HA1SA

NOMESCO Finland

Expansion mammography

5.0

11.0

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

10.1

11.0

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

9.2

11.0

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

13.9

11.0

HAD40

NOMESCO Finland

Mastopexy

4.7

10.9

159

Kela drug reimbursment

Pazopanib

11.9

10.8

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

2.9

10.8

165

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

9.6

10.7

HAD20

NOMESCO Finland

Liposuction of breast

9.6

10.7

9680/3-C42.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bone marrow

28.1

10.7

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

3.4

10.7

109

C54.21

ICD-10 Finland

Leiomyosarcoma and myometrium

21.5

10.7

TK800

NOMESCO Finland

Hemodialysis

2.5

10.7

257

Z43.3

ICD-10 Finland

Attention to colostomy

12.9

10.6

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.6

10.6

246

TAB00

NOMESCO Finland

Lumbar puncture

1.9

10.5

125

662

1523, ,

Kela drug reimbursment

5.0

10.5

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

10.1

10.5

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.9

10.5

173

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

2.8

10.4

179

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

5.4

10.4

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

7.7

10.4

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

10.4

168

981

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

3.6

10.4

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

16.1

10.3

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.4

10.3

107

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

9.6

10.2

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.6

10.2

227

P20

ICPC

Memory disturbance

0.6

10.2

146

2479

191

Kela drug reimbursment

Erlotinib

13.1

10.1

ZX114

NOMESCO Finland

Intramuscular

2.9

10.1

160

L01AA01

ATC

cyclophosphamide; systemic

5.3

10.1

SPAT1229

SPAT

Assessment of need for aid

1.7

10.1

194

1187

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.2

10.1

371

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

3.8

10.0

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.9

10.0

121

646

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

3.0

9.9

146

A98

ICPC

Health maint/preventive medicine

0.6

9.9

2624

27142

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

5.2

9.8

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

5.2

9.8

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

5.2

9.8

JEA00

NOMESCO Finland

Appendectomy

1.8

9.8

150

861

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

8.1

9.8

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

4.9

9.8

SPAT1262

SPAT

Handing over of treatment supplies

1.4

9.8

431

3164

A07EC01

ATC

sulfasalazine; oral, rectal

1.6

9.7

211

1332

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.2

9.7

384

A10AB05

ATC

insulin aspart; parenteral

1.7

9.7

192

1186

156

Kela drug reimbursment

Lapatinib

55.2

9.6

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

3.0

9.6

143

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

9.6

1010

8464

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

3.4

9.6

102

3054, ,

Kela drug reimbursment

4.8

9.5

GDC00

NOMESCO Finland

Lobectomy of lung

4.6

9.5

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.2

9.5

341

R06.0

ICD-10 Finland

Dyspnoea

1.3

9.5

723

5796

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

30.1

9.4

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

9.4

137

776

C62.11

ICD-10 Finland

Malignant tumor of the descending testicle, seminoma

21.8

9.3

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.8

9.3

162

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

8.0

9.3

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.4

9.3

I88.9

ICD-10 Finland

Nonspecific lymphadenitis, unspecified

4.4

9.3

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

4.0

9.3

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

4.7

9.3

L01EF02

ATC

ribociclib; oral

8.7

9.3

ECB20

NOMESCO Finland

Oral alveoplasty

3.0

9.3

130

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.0

9.3

465

UJK02

NOMESCO Finland

ERCP

2.2

9.3

345

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

9.2

181

1114

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.9

9.2

152

NF3AA

NOMESCO Finland

Femur X-ray examination

2.3

9.2

282

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

2.9

9.2

147

N06DX01

ATC

memantine; oral

0.3

9.2

932

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.4

9.2

258

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.9

9.1

142

N18.8

ICD-10 Finland

Other chronic renal failure

2.4

9.1

265

3009

Kela drug reimbursment

Niraparib

11.5

9.1

1510

Kela drug reimbursment

Niraparib

11.5

9.1

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

4.0

9.0

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

9.0

100

518

E61.2

ICD-10 Finland

Magnesium deficiency

15.6

9.0

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

15.6

9.0

372

Kela drug reimbursment

Idelalisib

36.8

9.0

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.8

9.0

149

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.1

9.0

383

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

3.8

9.0

J02AC01

ATC

fluconazole; systemic

1.3

9.0

1050

8901

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.1

8.9

117

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.1

8.9

370

JAH21

NOMESCO Finland

Staging laparoscopy

18.6

8.9

WX730

NOMESCO Finland

Conventional respirator

2.8

8.9

155

J02AC04

ATC

posaconazole; systemic

24.1

8.9

9673/3-C77.9

ICD-O-3

Mantle cell lymphoma of lymph node, NOS

24.1

8.9

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

2.6

8.8

184

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

8.8

217

1412

J02AC03

ATC

voriconazole; systemic

8.0

8.8

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

4.7

8.8

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.9

8.8

113

615

LCD00

NOMESCO Finland

Hysterectomy

1.8

8.8

131

747

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

8.8

315

2223

L01XK02

ATC

niraparib; oral

10.7

8.8

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.8

8.8

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.9

8.7

101

531

A07EA06

ATC

budesonide; oral, local oral

2.0

8.7

503

Z94.0

ICD-10 Finland

Kidney transplant status

3.1

8.7

119

C84.59

ICD-10 Finland

Other and unspecified T-cell lymphomas

14.1

8.7

9085/3-C62.9

ICD-O-3

Mixed germ cell tumor of testis, NOS

50.1

8.7

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

8.7

422

F20.5

ICD-10 Finland

Residual schizophrenia

4.3

8.7

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

3.5

8.6

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

11.6

8.6

Y77

ICPC

Malignant neoplasm prostate

2.1

8.6

350

E87.6

ICD-10 Finland

Hypokalaemia

1.9

8.6

514

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

8.5

324

2311

176

Kela drug reimbursment

Regorafenib

6.9

8.5

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

9.0

8.5

Z94.2

ICD-10 Finland

Lung transplant status

9.0

8.5

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

10.0

8.5

8441/3-C54.1

ICD-O-3

Serous carcinoma, NOS, of endometrium

10.0

8.5

C84.51

ICD-10 Finland

Other and unspecified T-cell lymphomas

27.6

8.5

C54.2

ICD-10 Finland

Malignant neoplasm: Myometrium

20.1

8.5

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

8.4

985

8329

L02BB03

ATC

bicalutamide; oral

2.4

8.4

249

L01AX03

ATC

temozolomide; systemic

3.7

8.4

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

7.3

8.4

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.9

8.4

132

A29

ICPC

General symptom/complaint other

1.4

8.4

353

2565

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

2.7

8.4

160

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

4.3

8.4

K83.0

ICD-10 Finland

Cholangitis

2.7

8.4

166

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

12.8

8.4

B29

ICPC

Lymph/immune mech sympt/complt other

4.5

8.4

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

4.9

8.4

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

3.4

8.3

HAC25

NOMESCO Finland

Radical mastectomy

4.7

8.3

OAA67, ,

SPAT

0.6

8.3

180

2762

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.4

8.3

220

E86

ICD-10 Finland

Volume depletion

2.2

8.3

289

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

8.5

8.3

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

8.5

8.3

3002

Kela drug reimbursment

Ribociclib

8.5

8.3

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

10.8

8.3

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

4.1

8.3

K56.7

ICD-10 Finland

Ileus, unspecified

2.5

8.2

203

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.4

8.2

JN5AN

NOMESCO Finland

Total body isotope imaging

14.5

8.2

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

14.5

8.2

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

8.2

177

1118

E000006, ,

ATC

1.6

8.2

167

1040

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.4

8.2

222

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

3.9

8.1

N05AE04

ATC

ziprasidone; systemic

4.4

8.1

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.7

8.1

527

6638

WPA44, ,

SPAT

4.5

8.1

ZYY01

NOMESCO Finland

Contact between professionals

4.5

8.1

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

2.6

8.1

169

1514, ,

Kela drug reimbursment

8.1

C84.49

ICD-10 Finland

Peripheral T-cell lymphoma, unspecified cell type

17.2

8.1

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

17.2

8.1

B73

ICPC

Leukaemia

11.7

8.1

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

2.9

8.1

130

V03AF03

ATC

calcium folinate; systemic

8.9

8.0

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

8.0

152

928

120

Kela drug reimbursment

Hypogammaglobulinaemia

10.0

8.0

T80.8

ICD-10 Finland

Other complications following infusion, transfusion and therapeutic injection

10.0

8.0

R60.0

ICD-10 Finland

Localized oedema

1.4

8.0

332

2407

1DB03, ,

NOMESCO Finland

22.1

8.0

KA1FN

NOMESCO Finland

Isotope renography

3.6

8.0

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

4.1

8.0

N05AX08

ATC

risperidone; systemic

1.6

8.0

188

1212

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.0

8.0

408

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

3.4

7.9

N05AF03

ATC

chlorprothixene; systemic

2.2

7.9

295

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

4.4

7.9

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

3.0

7.9

110

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

4.0

7.9

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

6.6

7.9

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

6.6

7.9

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

7.8

7.9

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.3

7.9

251

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.7

7.9

448

5753

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

3.6

7.8

A07EC02

ATC

mesalazine; oral, rectal

1.7

7.8

130

766

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.2

7.8

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

8.5

7.8

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

3.4

7.8

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

10.8

7.8

SPAT1290

SPAT

Preparation of deceased person

10.8

7.8

NFR30

NOMESCO Finland

Extended excision of soft tissue tumour of hip or thigh

9.4

7.8

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

4.2

7.7

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.3

7.7

253

-50

ICPC

Medication/prescr/renewal

1.8

7.7

104

576

9663/3-C77.8

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions

45.1

7.7

8890/3-C54.2

ICD-O-3

Leiomyosarcoma, NOS, of myometrium

45.1

7.7

D70.81

ICD-10 Finland

Neutropenia congenital

15.1

7.7

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

3.1

7.7

101

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

6.4

7.7

WW200, ,

SPAT

0.8

7.7

549

6829

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

7.4

7.7

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

7.7

272

1916

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1321

4751

4.27

317.42

9.2

3.4

0.79

0.82

mmol/l

21.20

1299

4484

(3017181) Myelocytes/Leukocytes in Blood

952

2548

5.08

307.65

6.1

4.5

1.42

0.90

6.41

722

752

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

363

355

11.55

307.65

2.0

1.6

—

(4035726) Immunohistochemistry procedure

976

2536

5.30

307.65

1.8

1.4

—

(3023368) Bacteria identified in Blood by Culture

2018

7442

6.65

307.65

9.0

4.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

516

731

8.37

307.65

2.3

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

516

758

8.07

307.65

2.4

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

444

504

10.22

307.65

2.3

1.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

472

587

9.41

307.65

7.9

5.3

439.24

565.44

iu/ml

0.21

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1281

4595

4.21

307.06

2.9

1.9

—

(3004809) Band form neutrophils/Leukocytes in Blood

374

440

9.61

298.80

4.2

3.7

2.45

1.36

4.20

356

395

(3021440) Promyelocytes/Leukocytes in Blood

860

2445

4.58

278.88

6.1

4.5

0.27

0.11

6.85

629

650

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

259

195

14.49

278.69

1.5

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

249

176

15.38

277.62

2.7

2.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

327

360

10.11

274.17

2.1

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

370

478

8.73

273.82

2.4

1.6

—

(3045142) Bone marrow Pathology biopsy report

316

333

10.53

273.55

1.8

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

555

1130

5.84

266.81

2.6

1.9

1.70

1.83

ug/l

0.11

534

1015

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

361

473

8.58

263.83

3.5

2.7

20289.36

1568.03

u/ml

0.60

(3011412) CD3 cells [#/volume] in Blood

270

240

12.30

262.33

3.1

2.1

990.36

1161.43

e6/l

1.62

256

216

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

988

3241

4.11

262.17

9.0

4.5

255.93

244.94

u/l

1.20

971

3080

(3002179) Metamyelocytes/Leukocytes in Blood

837

2438

4.42

261.21

5.9

4.3

1.00

0.68

4.29

611

722

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

747

2017

4.64

256.92

2.3

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2407

14482

4.92

252.91

21.6

6.8

10.02

11.32

umol/l

5.83

2374

13846

(1175426) CD3 cells/Lymphocytes in Blood

241

190

13.74

252.09

2.7

2.0

75.86

72.37

1.65

236

178

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1007

3449

3.94

249.58

2.5

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

969

3245

3.98

247.88

2.6

1.9

—

(21494814) CD8 cells/Lymphocytes in Specimen

195

107

19.47

246.72

2.4

1.9

40.29

29.95

7.34

195

107

(3013650) Neutrophils [#/volume] in Blood by Automated count

2483

15583

5.16

238.76

37.4

9.9

3.20

4.08

e9/l

96.06

2382

13520

(3025159) Blasts/Leukocytes in Blood

813

2472

4.18

237.10

6.4

4.7

0.13

0.23

0.31

575

615

(40768795) Lymph node Pathology biopsy report

264

282

10.20

225.54

1.6

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

233

215

11.70

220.37

2.1

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

352

555

7.08

217.44

1.9

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

378

657

6.47

212.34

2.0

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

878

3018

3.74

212.02

6.2

4.3

25.62

21.40

ug/l

0.24

733

2442

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

177

111

16.92

209.61

4.8

3.3

1.75

1.31

1.18

177

111

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

306

453

7.43

199.93

2.0

1.5

—

(3018418) pH of Serum or Plasma

1629

8467

3.11

194.00

10.4

4.3

7.40

5.48

1392

6109

(3019069) Monocytes/Leukocytes in Blood

2111

12797

3.40

190.52

12.6

6.8

9.89

8.85

19.90

2059

12004

(42870588) Differential panel, method unspecified - Blood

1729

9360

3.10

190.20

11.3

6.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

328

555

6.54

188.63

2.0

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

188

161

12.42

186.27

2.1

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

690

2201

3.80

183.54

10.5

3.9

1.23

mmol/l

0.38

666

1914

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

189

168

11.97

182.81

2.1

1.6

—

(3002030) Lymphocytes/Leukocytes in Blood

2116

13066

3.30

180.33

12.6

6.7

27.27

27.76

0.88

2069

12394

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

234

288

8.75

178.68

1.4

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

193

184

11.17

178.13

2.1

1.5

—

(3006504) Eosinophils/Leukocytes in Blood

2079

12760

3.23

177.95

12.5

6.7

2.25

2.84

22.47

2028

11962

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2204

13998

3.40

177.70

15.2

7.6

1.21

mmol/l

1.03

1755

12162

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2058

12589

3.19

176.55

13.1

6.9

1.21

mmol/l

0.06

2007

11648

(3022096) Basophils/Leukocytes in Blood

2071

12760

3.19

174.46

12.5

6.8

0.65

0.69

2.29

2020

11954

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

210

250

8.98

164.49

1.7

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

606

1918

3.73

161.41

1.6

1.4

—

(3018010) Neutrophils/Leukocytes in Blood

2032

12845

2.95

154.31

11.6

6.6

55.09

57.28

7.91

2005

12274

(40760892) CBC W Ordered Manual Differential panel - Blood

1223

5978

2.81

153.55

10.5

4.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

638

2176

3.48

150.72

5.4

2.9

9.05

10.63

g/l

9.94

616

2008

(3024561) Albumin [Mass/volume] in Serum or Plasma

1966

12360

2.84

148.08

9.9

5.3

32.84

35.68

g/l

76.06

1905

11635

(3027945) Reticulocytes/Erythrocytes in Blood

793

3160

3.08

143.87

4.3

2.6

1.80

1.82

0.16

750

2813

(3006315) Basophils [#/volume] in Blood

2115

13932

2.92

143.35

12.1

6.5

0.03

0.04

e9/l

44.95

1952

11923

(3001604) Monocytes [#/volume] in Blood

2109

13897

2.90

142.37

12.1

6.4

0.56

0.58

e9/l

0.60

1947

11895

(3000850) Epithelial cells [#/volume] in Urine

1212

6137

2.68

138.73

3.6

2.7

6.40

5.85

e6/l

0.62

1157

5590

(3019198) Lymphocytes [#/volume] in Blood

2129

14194

2.89

138.66

12.4

6.5

1.55

1.93

e9/l

11.26

1990

12468

(3013115) Eosinophils [#/volume] in Blood

2140

14373

2.87

136.10

13.2

6.7

0.13

0.19

e9/l

64.47

1989

12510

(3032080) INR in Blood by Coagulation assay

1944

12444

2.71

135.99

12.9

14.9

1.15

1.24

inr

15.49

1745

10290

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

207

307

7.18

134.12

2.3

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

730

2886

3.04

133.14

1.7

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

711

2788

3.05

131.39

6.5

3.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1633

9774

2.54

128.73

9.5

3.6

2.34

2.36

mmol/l

5.35

1581

8873

(40761536) Microorganisms panel - Urine sediment

589

2094

3.28

128.46

5.4

4.1

—

(3000012) Reticulocyte production index

227

392

6.20

126.92

2.6

2.2

0.91

0.04

201

266

(3023520) Reticulocytes [#/volume] in Blood

648

2455

3.11

126.74

4.1

2.7

68.57

70.28

e9/l

0.53

534

1797

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

193

282

7.26

126.68

2.4

1.7

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

29.44

124.60

2.1

2.4

1.72

1.47

mg/l

0.20

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

283

610

5.03

124.16

1.6

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

321

770

4.56

123.62

1.8

—

(3028026) IgM [Mass/volume] in Serum or Plasma

512

1735

3.37

120.22

2.9

1.9

1.13

1.36

g/l

1.71

489

1595

(3026782) Osmolality of Urine

1039

5172

2.57

119.46

3.6

3.0

497.07

520.88

mosm/kgh2o

3.29

975

4536

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

813

3589

2.76

119.21

1.8

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

835

3784

2.70

115.82

8.8

6.3

1.02

1.04

mmol/l

0.78

818

3514

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

282

646

4.73

114.79

1.6

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

1489

8852

2.40

114.60

4.5

3.4

118.77

70.38

e6/l

0.47

1276

6735

(3042936) Bacteria identified in Isolate by Culture

854

3956

2.64

112.92

2.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2634

20704

4.01

111.77

27.3

8.6

89.34

79.30

u/l

13.91

2608

19690

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

250

538

4.99

109.61

1.5

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

205

371

5.87

108.97

2.0

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

205

371

5.87

108.97

2.0

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

205

371

5.87

108.97

2.0

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

205

371

5.87

108.97

2.0

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1888

12665

2.41

107.36

5.0

2.8

—

estimate

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

315

832

4.13

106.46

1.7

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

419

1354

3.45

105.35

1.8

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

1322

7663

2.33

105.18

4.2

3.3

0.46

0.41

e6/l

0.32

1117

5594

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

293

747

4.25

103.78

1.3

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

169

269

6.61

102.15

4.8

4.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2324

17327

2.73

102.09

6.3

4.8

679.80

1311.74

e6/l

0.57

233

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

136

173

8.20

100.49

3.8

2.2

0.42

0.71

e9/l

4.24

120

166

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

158

239

6.93

100.21

2.5

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

158

239

6.93

100.21

2.5

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

158

239

6.93

100.21

2.5

1.5

—

(3042631) Mycobacterium sp identified in Specimen

199

379

5.56

100.06

2.2

2.9

—

(3012501) Base excess in Blood by calculation

235

533

4.71

96.50

3.9

4.6

2.31

2.63

mmol/l

0.95

176

366

(3013290) Carbon dioxide [Partial pressure] in Blood

235

534

4.70

96.27

3.9

4.6

4.84

5.04

kpa

3.83

230

528

(3027315) Oxygen [Partial pressure] in Blood

235

537

4.67

95.60

3.9

4.7

8.64

8.55

kpa

0.30

230

530

(3044640) Blood type and Crossmatch panel - Blood

1435

8903

2.21

93.49

4.8

2.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

331

992

3.64

92.99

2.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

843

4209

2.41

92.19

3.2

2.1

29.61

29.51

0.20

829

4102

(3021589) Normoblasts [#/volume] in Blood

1777

12048

2.23

92.09

31.1

11.6

0.00

e9/l

1.68

1565

9842

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1405

8720

2.19

90.54

3.8

2.7

52.28

69.84

u/l

1.23

1340

8077

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

217

488

4.73

89.93

1.6

1.4

134.50

154.96

au/ml

1.41

147

(3013826) Glucose [Moles/volume] in Serum or Plasma

2154

15903

2.38

89.45

9.7

5.2

6.66

6.67

mmol/l

0.11

2106

15128

(3018095) Leukocytes [#/volume] in Urine

1557

10104

2.17

88.99

5.3

4.1

89.36

94.70

e6/l

0.09

1306

7089

(3010421) pH of Blood

303

883

3.72

88.61

4.0

3.9

7.43

7.41

8.77

298

877

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

124

165

7.81

88.13

4.9

2.8

35.76

41.91

2.23

(46235355) HIV 1 and 2 tests - Meaningful Use set

816

4132

2.36

85.46

1.9

1.8

—

(3026008) Bacteria identified in Urine by Culture

1332

8282

2.13

83.32

3.6

3.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

413

1576

2.89

77.00

9.7

3.7

62.30

71.94

u/ml

0.34

400

1523

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

211

525

4.26

76.72

1.4

1.2

—

58.82

—

(1616796) Gas panel - Central venous blood

221

585

4.01

73.86

3.9

4.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

596

2801

2.42

72.51

2.5

2.2

0.20

0.21

g/l

5.01

569

2637

(3029937) Albumin [Presence] in Urine by Test strip

1242

7809

2.03

72.44

6.0

4.2

0.00

estimate

0.46

637

2730

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

199

495

4.24

72.32

1.4

1.2

255.65

269.50

u/ml

0.26

137

300

(40768793) Breast Pathology biopsy report

258

781

3.53

70.85

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

213

568

3.97

70.40

3.0

2.7

14.55

16.35

11.86

208

560

(3036481) Cortisol [Moles/volume] in Serum or Plasma

567

2677

2.39

67.86

3.1

2.2

372.67

376.14

nmol/l

0.15

548

2475

(3017354) Segmented neutrophils/Leukocytes in Blood

144

290

5.17

67.79

3.7

51.38

57.90

2.24

129

250

(3004789) Transferrin [Mass/volume] in Serum or Plasma

797

4371

2.14

66.10

2.6

2.7

2.14

2.32

g/l

12.99

759

4049

(3025941) Bacteria identified in Stool by Culture

367

1421

2.81

66.10

1.5

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

160

361

4.63

65.81

1.2

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

106

164

6.67

65.66

3.5

2.2

553.33

508.44

e6/l

0.24

135

(3020630) Protein [Mass/volume] in Serum or Plasma

522

2420

2.41

64.84

4.0

2.9

64.22

66.52

g/l

8.11

505

2232

(3037692) Legionella sp identified in Specimen by Organism specific culture

111

8.05

63.99

1.5

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

242

764

3.37

62.04

1.4

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

825

4677

2.07

62.04

2.7

13.09

13.06

umol/l

0.03

793

4365

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

740

4039

2.12

61.51

2.6

2.7

25.27

22.60

2.88

709

3760

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

164

403

4.25

60.45

5.2

7.1

12.09

12.13

mg/l

0.04

157

377

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

421

1837

2.51

59.33

7.3

8.8

24.79

24.92

mmol/l

0.33

416

1830

(3020779) Urea [Moles/volume] in Serum or Plasma

525

2538

2.31

58.77

10.1

8.1

8.69

9.78

mmol/l

3.59

511

2443

(3004588) Protein electrophoresis panel - Serum or Plasma

442

1982

2.45

58.68

2.9

2.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

164

6.21

57.35

3.8

2.3

187.89

214.65

e6/l

0.50

144

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

132

286

4.79

56.99

2.6

2.4

13.85

35.93

iu/ml

1.46

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

208

634

3.46

56.27

5.3

3.6

280.74

862.33

u/ml

0.76

196

589

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

243

816

3.16

56.18

2.8

2.4

3.77

3.60

g/l

0.83

235

778

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

148

6.39

54.86

1.3

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

118

241

5.06

54.61

1.0

1.1

—

(40758558) Short blood count panel - Blood

1247

8442

1.84

53.40

24.1

6.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

10.36

52.04

3.0

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

596

3173

2.11

51.84

1.9

1.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

9.28

50.49

1.6

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1430

10230

1.79

49.80

4.8

3.8

24.00

110.31

ng/l

1.26

1200

7223

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

140

358

4.06

48.86

2.9

1.8

22.02

26.92

ug/l

0.55

140

351

(40765096) Chromosome analysis panel by Banding

104

7.17

48.77

1.2

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

144

6.05

48.13

3.2

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

144

6.05

48.13

3.2

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

144

6.05

48.13

3.2

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

144

6.05

48.13

3.2

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

112

6.85

48.00

3.4

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

202

668

3.18

47.79

3.3

3.4

8.22

8.08

kpa

0.57

197

657

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1313

9245

1.77

47.56

6.9

3.3

37.11

33.00

u/l

2.16

1261

8731

(40768806) Pleura Pathology biopsy report

120

280

4.43

47.24

1.4

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

111

6.82

47.16

3.4

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

111

6.82

47.16

3.4

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2330

25895

0.49

46.52

5.3

6.1

2.69

2.72

mmol/l

0.78

2118

24123

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1442

10473

1.75

46.49

5.8

4.0

0.00

0.08

estimate

1.11

604

2378

(3032352) Blasts [#/volume] in Cerebral spinal fluid

13.73

45.10

2.6

1.8

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

106

6.74

44.22

1.9

2.2

716.38

29604.06

u/ml

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2272

25399

0.51

43.94

4.8

5.2

1.45

1.49

mmol/l

3.19

2064

23606

(3041096) Erythrocytes [Presence] in Urine by Automated

1086

7410

1.74

42.59

5.4

3.4

0.01

0.16

estimate

0.77

596

2282

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

577

3258

1.96

41.68

5.4

2.7

13.13

7.90

umol/l

3.31

525

2872

(3021901) Oxygen saturation in Capillary blood

174

572

3.17

41.51

3.2

3.0

90.31

89.90

0.33

169

559

(3003694) ABO and Rh group [Type] in Blood

1081

7409

1.73

41.44

1.8

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2301

25549

0.52

41.03

4.9

5.3

4.64

4.67

mmol/l

0.76

2120

23898

(21494434) Karyotype in Bone marrow

108

264

4.21

40.03

1.4

1.2

—

(40768804) Tissue Pathology biopsy report

1486

11180

1.68

39.65

2.6

2.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

867

5639

1.77

39.62

5.7

3.0

2.48

2.45

mmol/l

5.92

814

5084

(3009343) pH of Capillary blood

367

1788

2.21

39.28

4.3

3.9

7.43

7.42

2.48

328

1506

(3033658) Prothrombin time (PT) actual/Normal

1032

7064

1.72

39.22

7.0

4.1

89.17

90.69

1.32

1018

6906

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

332

1555

2.28

39.09

4.2

3.7

2.27

1.86

mmol/l

1.15

253

1187

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1003

6821

1.72

38.98

4.7

2.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

219

849

2.71

38.74

1.9

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

373

1841

2.18

38.61

4.4

3.9

4.94

5.16

kpa

5.22

361

1777

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

224

890

2.64

37.73

3.2

0.36

iu/ml

0.03

133

490

(3018405) Lactate [Moles/volume] in Arterial blood

222

887

2.63

36.96

4.4

3.9

1.52

1.38

mmol/l

0.76

214

874

(3009261) Glucose [Presence] in Urine by Test strip

1794

14319

1.66

36.85

5.9

4.0

0.02

0.12

estimate

0.47

674

2792

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

253

1081

2.47

36.61

4.4

3.6

3026.27

1622.77

u/ml

0.21

224

929

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

100

249

4.12

36.17

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

214

849

2.64

36.13

2.6

2.1

89.82

92.44

0.82

207

818

(3021601) Nitrite [Presence] in Urine by Test strip

1764

14059

1.65

36.06

5.9

4.0

0.00

estimate

0.80

680

2912

(3035350) Ketones [Presence] in Urine by Test strip

1775

14199

1.65

35.48

5.9

4.0

1.99

3.73

estimate

0.32

688

2989

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

347

1730

2.14

34.84

2.4

1.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

154

528

3.02

34.15

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

154

528

3.02

34.15

1.5

1.3

—

(3002256) Pathology report gross observation

618

3788

1.80

33.76

1.4

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

186

4.51

33.46

1.3

1.2

79.14

85.90

—

(3016502) Oxygen saturation in Arterial blood

503

2911

1.88

33.01

9.6

8.7

95.72

95.69

0.03

487

2824

(3021447) Carbon dioxide [Partial pressure] in Venous blood

488

2801

1.89

32.84

4.5

3.8

5.62

5.82

kpa

4.81

477

2730

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

275

1286

2.26

32.30

1.9

1.8

1.66

1.56

g/l

0.71

242

1124

(3024471) HLA-A [Type]

6.64

31.92

1.0

—

(3037756) Immunofixation for Serum or Plasma

166

617

2.79

31.78

1.8

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

121

375

3.32

31.78

1.4

1.5

36.51

32.91

g/l

2.53

112

339

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

200

819

2.55

31.59

4.2

3.3

1.54

1.60

mg/l

0.51

187

748

(3019977) pH of Arterial blood

543

3267

1.81

31.31

9.4

8.3

7.42

7.41

1.68

353

1758

(3012441) Differential panel - Pleural fluid

103

291

3.63

31.20

1.4

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

136

458

3.07

31.11

1.1

—

(3000494) Fungus identified in Specimen by Culture

566

3457

1.79

31.00

1.9

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2205

24490

0.58

30.93

6.0

6.6

39.30

39.29

mmol/mol

0.01

2029

22920

(3028433) Virus identified in Specimen by Culture

6.05

30.30

1.3

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

233

1043

2.34

30.28

3.4

2.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.82

30.23

1.2

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

100

284

3.61

30.06

1.7

1.6

—

(40768441) Liver Pathology biopsy report

220

4.00

30.01

1.4

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

326

1678

2.06

29.90

9.5

7.5

24.70

24.60

mmol/l

0.17

316

1603

(3012544) pH of Venous blood

482

2838

1.84

29.68

4.6

3.8

7.39

7.38

2.52

319

1611

(3027801) Oxygen [Partial pressure] in Arterial blood

537

3278

1.78

29.31

9.5

8.3

12.79

12.47

kpa

0.67

520

3161

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

537

3279

1.78

29.28

9.5

8.3

5.01

5.13

kpa

2.11

517

3162

(3002032) Base excess in Venous blood by calculation

466

2727

1.84

29.24

4.7

3.8

1.97

1.85

mmol/l

0.28

411

2398

(3015235) Bicarbonate [Moles/volume] in Capillary blood

221

985

2.35

28.99

3.2

3.0

24.25

24.91

mmol/l

1.46

215

975

(3017732) Neutrophils [#/volume] in Blood

573

3576

1.75

28.93

7.6

3.3

3.78

4.53

e9/l

2.38

529

3090

(3003396) Base excess in Arterial blood by calculation

532

3252

1.78

28.86

9.4

8.2

1.53

0.96

mmol/l

2.80

439

2700

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

9.81

28.56

1.9

1.7

—

(3023419) Bacteria identified in Sputum by Culture

121

402

3.10

28.34

2.2

2.7

—

(3006245) CD3-CD19+ cells/cells in Blood

5.97

28.24

3.2

2.2

11.14

9.00

0.33

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

115

372

3.18

28.17

1.5

1.4

0.26

0.33

nmol/l

0.84

274

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

994

7191

1.58

28.02

2.4

2.3

3.16

2.81

mg/l

3.78

901

6215

(3024932) HLA-DR beta [Type]

6.27

27.90

1.3

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

6.42

27.35

1.2

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

864

11673

0.63

27.32

2.1

2.0

1.48

1.36

mmol/l

3.05

689

9806

(40758292) HTLV I+II Ab panel - Serum

7.45

27.15

1.4

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

984

7159

1.57

26.78

5.9

2.8

321.57

338.13

umol/l

5.20

920

6320

(3002173) Hemoglobin [Mass/volume] in Arterial blood

457

2738

1.79

26.34

10.5

9.2

111.81

121.10

g/l

18.12

447

2678

(3026250) Tacrolimus [Mass/volume] in Blood

116

4.90

25.53

46.1

38.1

7.45

7.53

ug/l

0.08

102

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

160

656

2.52

25.18

2.1

1.4

651.81

1146.62

e6/l

0.39

145

501

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

158

645

2.53

25.09

2.1

1.4

12.83

39.17

e6/l

1.09

134

460

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

118

4.82

25.03

1.9

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

118

4.82

25.03

1.9

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1090

8210

1.53

24.89

3.6

3.2

1492.12

1169.82

ng/l

1.33

990

7083

(3000991) Gas panel - Venous blood

416

2474

1.80

24.45

9.8

9.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

6.29

24.45

1.5

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

846

6046

1.56

24.44

2.2

1.8

1.99

1.23

mg/l

4.33

678

4728

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

174

752

2.40

24.43

1.9

1.3

763.84

536.04

mg/l

0.83

167

715

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2212

24284

0.62

23.81

4.3

4.4

1.37

1.29

mmol/l

5.33

2005

22332

(3001964) Herpes simplex virus Ag [Presence] in Specimen

5.80

23.67

1.8

1.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

5.42

23.54

1.7

1.2

21.77

8.90

—

(3007164) IgA [Mass/volume] in Serum or Plasma

777

5486

1.57

23.51

2.4

1.5

2.10

2.46

g/l

6.08

604

3327

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

107

369

2.97

23.51

2.4

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

6.51

23.46

3.2

2.0

0.09

0.13

e9/l

0.47

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

204

962

2.21

23.34

2.5

1.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

107

371

2.96

23.29

2.4

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

107

374

2.93

22.96

2.4

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

254

3.33

22.29

1.3

1.4

479.21

361.70

u/l

0.67

245

(3030981) Hyaline casts [#/volume] in Urine by Automated count

377

2258

1.77

21.48

3.5

2.5

0.28

0.44

e6/l

1.81

366

2153

(3025468) Yersinia sp identified in Specimen by Organism specific culture

100

350

2.92

21.42

2.4

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

100

350

2.92

21.42

2.4

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

188

3.68

21.33

1.4

12.15

13.28

u/l

0.38

179

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

6.60

21.29

1.4

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

100

352

2.91

21.20

2.4

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

164

3.84

20.72

1.9

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

172

796

2.23

20.60

2.9

2.4

205.99

195.46

0.80

166

758

(3000093) Morphology [Interpretation] in Blood Narrative

252

3.24

20.53

1.2

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

384

2341

1.74

20.52

4.0

3.2

4.59

4.58

kpa

0.03

377

2276

(3006184) Hemoglobin [Mass/volume] in Capillary blood

151

664

2.34

20.39

2.8

2.3

117.78

129.03

g/l

6.90

134

520

(3010375) cycloSPORINE [Mass/volume] in Blood

118

4.38

20.37

37.5

29.4

134.54

112.77

ug/l

1.19

(3044290) Cell count panel - Cerebral spinal fluid

142

608

2.40

20.36

2.0

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

171

3.74

20.30

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

162

3.82

20.28

1.9

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

123

494

2.56

20.23

1.2

1.3

—

(4281824) Cell count and differential, peritoneal fluid

327

2.91

19.78

1.3

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

134

4.09

19.71

1.8

1.3

62.92

75.75

0.47

(3003181) Sodium [Moles/volume] in Urine

128

535

2.46

19.36

1.3

1.4

64.54

61.46

mmol/l

0.38

437

(3008295) Osmolality of Serum or Plasma

322

2.89

19.14

1.2

1.3

277.33

276.81

mosm/kgh2o

0.08

247

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

139

607

2.35

19.08

4.4

2.0

354.72

4599.86

u/l

3.92

248

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

362

2217

1.72

18.95

5.2

2.7

57.64

65.61

ml/min/173m2

3.70

164

932

(3005532) Lymphocytes/Leukocytes in Pleural fluid

4.54

18.45

1.4

1.6

66.28

60.75

0.41

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

265

3.04

18.27

4.0

2.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

294

2.91

18.03

1.5

1.4

32798.37

96533.97

e6/l

1.17

158

(3023199) Leukocytes [#/volume] in Pleural fluid

341

2.75

17.77

1.5

1.4

2296.78

4856.68

e6/l

0.46

233

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

178

885

2.08

17.77

4.2

3.7

7.11

3.02

ratio

1.02

517

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1883

21042

0.70

17.49

55.7

21.4

330.80

331.89

g/l

6.43

1875

20947

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

115

481

2.45

17.39

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

7.08

17.38

1.2

1.1

—

(3015736) pH of Urine

1369

11292

1.40

17.33

4.8

3.5

6.33

6.23

2.55

883

6265

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

765

5685

1.47

17.25

1.8

1.7

27879271.29

34198752.41

pmol/l

0.12

660

4740

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.46

17.13

1.4

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

191

995

1.98

16.76

4.3

3.9

35.37

70.06

mg/l

1.25

137

859

(3034860) Kappa light chains.free [Mass/volume] in Serum

190

995

1.97

16.43

4.3

3.9

50.76

56.59

mg/l

0.27

137

859

(3040151) Glucose [Moles/volume] in Capillary blood

291

2.80

16.04

13.0

5.7

7.84

7.30

mmol/l

0.41

247

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

170

3.40

16.02

1.2

95.60

76.95

u/l

0.84

155

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

170

3.40

16.02

1.2

31.00

20.41

u/l

0.67

153

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

24.61

15.99

2.1

2.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

4.72

15.87

1.2

1.3

101.09

106.95

ug/l

0.03

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2332

24957

0.66

15.79

5.4

5.93

5.94

mmol/l

0.09

2151

22958

(3036489) Thrombin time

194

1041

1.93

15.62

2.7

2.0

21.04

21.19

0.14

178

925

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

610

4428

1.48

15.23

4.0

3.1

2.72

2.67

e6/l

0.04

333

2151

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

169

874

1.99

15.15

1.6

1.5

0.01

8.41

iu/ml

0.50

144

(3024891) Influenza virus A+B Ag [Presence] in Specimen

137

656

2.14

15.11

1.3

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2686

25407

1.79

14.72

48.3

16.6

28.57

23.83

mg/l

12.97

2566

21003

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

213

3.00

14.44

1.1

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

133

3.58

14.33

1.8

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

133

3.58

14.33

1.8

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

127

608

2.14

14.03

1.5

1.7

—

(3036782) Glucose [Moles/volume] in Pleural fluid

278

2.71

13.99

1.3

1.4

5.73

6.32

mmol/l

1.04

261

(40757373) Influenza virus identified in Isolate

5.13

13.63

2.0

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

371

2.44

13.62

1.4

—

(3035880) pH of Pleural fluid

143

3.40

13.56

1.3

1.4

7.37

7.40

0.42

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.55

13.53

1.4

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

213

1234

1.78

13.45

4.3

3.2

25.26

25.42

mmol/l

0.27

208

1193

(3014148) Varicella zoster virus Ab [Titer] in Serum

314

2.53

12.87

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

395

2.35

12.75

6.7

5.7

386.44

356.40

umol/l

1.08

347

(3023183) Ammonium ion [Moles/volume] in Plasma

124

613

2.07

12.62

2.4

2.9

35.00

33.39

umol/l

0.24

108

556

(3045788) Cell count panel - Pleural fluid

283

2.58

12.49

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

595

4455

1.42

12.30

1.9

1.7

1412.36

1163.45

nmol/l

8.54

486

3363

(3009214) Lutropin [Units/volume] in Serum or Plasma

120

600

2.04

11.86

1.8

1.4

13.09

11.43

u/l

0.61

106

486

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2297

21226

1.40

11.62

54.0

20.4

14.61

13.64

119.75

2290

20960

(3044242) Glucose [Moles/volume] in Arterial blood

163

3.04

11.61

2.4

2.1

8.64

8.84

mmol/l

0.09

163

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

139

738

1.93

11.59

1.5

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

635

4859

1.39

11.49

3.9

3.0

1.24

1.04

e6/l

0.51

358

2593

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1464

12694

1.31

11.34

3.0

2.5

78.88

78.50

nmol/l

0.19

1386

11484

(3014765) Yersinia sp identified in Stool by Organism specific culture

139

745

1.91

11.28

1.5

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

8.91

11.24

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

17.09

11.18

1.7

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

139

753

1.89

10.93

1.5

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

203

1236

1.69

10.76

8.0

5.8

1.61

1.57

0.18

193

1167

(3009871) Measles virus Ab [Titer] in Serum

109

3.43

10.69

1.7

2501.82

4062.22

titre

0.87

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

233

1473

1.63

10.68

3.4

2.9

0.65

0.61

1.16

233

1465

(3046861) Legionella sp Ag [Presence] in Urine

12.93

10.64

1.1

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

139

760

1.87

10.63

4.2

3.4

3.37

2.04

index

1.34

389

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

18.84

10.25

1.1

1.0

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

232

1488

1.61

10.04

3.4

2.9

1.23

1.20

0.28

232

1477

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1436

12541

1.29

10.02

3.4

3.1

357.52

126.27

ug/l

20.33

1357

11710

(3013862) HLA-DP [Type]

14.61

9.99

1.0

—

(3022145) Colonoscopy Study observation

444

3270

1.42

9.89

1.5

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

158

2607

0.58

9.89

1.9

2.0

3.74

3.44

ratio

0.59

122

2052

(3017569) Oxygen content in Arterial blood

168

2.83

9.85

2.7

2.3

14.01

16.44

4.94

168

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

182

2.72

9.57

3.0

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

5.03

9.56

1.8

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

348

2.22

9.48

2.1

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

183

2.71

9.48

1.6

3.66

6.13

u/l

1.37

152

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

133

745

1.82

9.45

1.6

2.1

11.46

12.10

mg/l

0.12

128

690

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

103

3.33

9.44

1.1

—

(3022313) Gas panel - Capillary blood

201

1266

1.63

9.37

5.1

4.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

8.69

9.28

1.2

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

125

3.07

9.24

3.5

4.7

—

(40760409) HLA-A [Type] by High resolution

13.70

9.17

1.0

—

(40760410) HLA-B [Type] by High resolution

13.70

9.17

1.0

—

(40763590) HLA-DQ beta [Type]

13.70

9.17

1.0

—

(46236302) HLA-C [Type] by High resolution typing

13.70

9.17

1.0

—

(21494755) Public health laboratory ask at order entry panel

114

2008

0.55

9.05

1.2

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

3.99

9.05

1.6

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

189

1183

1.64

9.03

1.7

1.4

34.89

30.97

iu/l

0.74

158

1022

(3042733) HLA Ab [Presence] in Serum

3.56

8.94

5.4

4.9

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

377

2750

1.43

8.82

3.4

2.5

30.93

55.62

u/l

0.79

331

2327

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.52

8.79

1.1

1.2

616.67

900.00

titre

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

16.32

8.54

1.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2286

24124

0.75

8.50

6.0

5.7

2.00

1.93

mu/l

1.55

2139

22372

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

191

1220

1.61

8.43

1.6

1.9

41.97

38.89

u/l

0.97

176

1089

(3012516) Albumin [Mass/volume] in Urine

776

9313

0.77

8.42

3.7

3.5

43.62

45.46

mg/l

0.13

480

5811

(3020682) Albumin/Creatinine [Ratio] in Urine

791

9456

0.78

8.29

4.5

4.2

9.84

8.46

mg/mmol

0.46

471

5777

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

160

988

1.66

8.09

5.5

4.1

25.16

24.90

mmol/l

0.50

153

920

(3047181) Lactate [Moles/volume] in Blood

135

800

1.72

7.96

9.6

7.1

1.34

1.29

mmol/l

0.29

116

707

(3016038) Potassium [Moles/volume] in Urine

183

2.54

7.91

1.1

36.16

33.90

mmol/l

0.31

163

(3007930) Methemoglobin/Hemoglobin.total in Blood

179

1146

1.60

7.84

8.7

6.1

0.83

0.87

0.63

169

1078

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

113

1914

0.57

7.80

1.7

1.8

3.50

3.49

mmol/l

0.03

1364

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

549

4342

1.33

7.71

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

198

2.45

7.66

2.2

1.7

1.41

4.28

ug/l

1.33

161

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1014

8695

1.26

7.52

3.0

2.2

179.56

203.84

u/l

0.32

966

8247

(3037121) Protein [Mass/volume] in Urine

153

956

1.63

7.41

6.2

3.6

422.50

306.67

mg/l

0.24

105

416

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

455

5782

0.75

7.36

4.6

21.39

21.48

0.04

250

2883

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

166

1066

1.59

7.19

4.0

2.6

1.38

1.07

g/l

0.28

140

922

(3019832) Treponema pallidum Ab [Presence] in Serum

256

1806

1.46

7.15

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

138

848

1.66

7.14

2.3

1.7

0.23

g/l

0.52

130

813

(1002224) Polysomnography panel

1260

0.50

7.09

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

164

2.52

7.01

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

936

8004

1.25

7.00

1.8

1.7

19.46

20.77

nmol/l

1.89

839

6721

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

435

1.91

6.99

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

132

807

1.67

6.97

1.3

1.2

106.67

88.82

titre

0.28

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

338

2.04

6.97

1.4

39.78

31.71

u/l

1.08

277

(3004119) Hemoglobin [Mass/volume] in Venous blood

251

1775

1.45

6.93

3.9

3.3

114.77

129.07

g/l

17.30

246

1720

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

13.80

6.88

1.1

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

142

2.63

6.87

1.9

7.1

—

55.45

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

9.32

6.78

1.5

1.1

1.34

1.18

iu/ml

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

144

908

1.62

6.75

3.5

2.5

0.04

0.01

g/l

0.40

130

814

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2123

19881

1.25

6.58

7.0

4.6

18.55

12.30

mm/h

36.29

2018

18639

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

159

1033

1.57

6.58

2.6

2.2

306.02

650.64

ug/l

0.94

148

980

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

139

875

1.62

6.57

2.3

1.7

1.15

1.18

g/l

0.51

132

841

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

447

1.86

6.46

1.2

1.1

—

1.32

—

(40768446) Kidney Pathology biopsy report

107

2.82

6.42

1.5

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

231

2.18

6.23

1.2

113.80

107.68

pmol/l

0.29

231

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.92

6.15

1.1

2.0

25625.00

24906.94

e6/l

0.01

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

332

4310

0.74

6.12

2.7

3.3

0.89

0.74

ug/l

1.16

228

2883

(3024980) IgG subclass 4 [Mass/volume] in Serum

463

1.82

6.10

1.5

1.7

0.62

0.78

g/l

0.72

363

(3009508) Creatinine [Moles/volume] in Urine

845

9759

0.81

6.02

3.8

3.5

6.64

7.32

mmol/l

5.24

701

8255

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

836

0.45

5.99

1.1

1.2

1.59

1.55

g/l

0.38

836

(4062490) Immunoglobulin typing, IgG

284

2.03

5.86

1.5

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2698

26185

1.44

5.82

44.7

19.5

139.04

139.74

mmol/l

37.56

2670

25718

(3043410) Blood group antigens tested for on Red Blood Cells

3.02

5.80

2.0

1.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

256

3430

0.72

5.77

4.4

5.2

31.58

32.69

0.82

181

2260

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

169

1151

1.50

5.68

3.6

2.6

3.19

2.90

g/l

2.53

164

1056

(3006922) Hepatitis E virus Ab [Presence] in Serum

214

2.17

5.66

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

275

2.02

5.62

4.6

3.3

12.63

12.09

index

0.19

160

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

139

2.46

5.61

1.0

1.1

1332.90

1566.42

miu/ml

0.58

139

(3020876) Protein [Mass/time] in 24 hour Urine

354

1.88

5.52

2.8

2.3

1.08

1.25

g/24h

0.13

213

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

134

874

1.56

5.50

3.6

2.5

0.00

g/l

-0.00

115

766

(3048879) Bone marrow aspiration report

3.07

5.49

2.0

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

3.63

5.48

1.2

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

287

1.97

5.36

1.5

1.4

0.40

0.38

g/l

0.12

210

(3028192) IgG subclass 2 [Mass/volume] in Serum

287

1.97

5.36

1.5

1.4

2.59

2.91

g/l

0.50

211

(3027135) IgG subclass 1 [Mass/volume] in Serum

287

1.97

5.36

1.5

1.4

6.55

6.74

g/l

0.12

209

(3023103) Potassium [Moles/volume] in Serum or Plasma

2699

26238

1.42

5.34

45.4

19.7

3.96

3.97

mmol/l

1.68

2670

25726

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

149

2.37

5.31

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

425

0.28

5.30

1.8

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

119

2.54

5.29

1.2

1.1

2019.38

392.77

ng/l

0.49

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

151

1023

1.50

5.23

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

108

2.61

5.22

1.1

2.2

733.55

850.36

e6/l

0.20

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

163

2.29

5.21

1.0

1.1

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

+∞

5.21

1.8

0.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.85

5.08

8.0

1.7

4.05

1310.13

pmol/l

0.57

(3047189) Immunofixation for 24 hour Urine

146

2.34

5.08

1.6

1.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

174

1224

1.45

5.00

3.5

2.5

4.02

4.23

g/l

2.87

169

1127

(3010937) Rubella virus Ab [Presence] in Serum

6.90

4.95

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.87

4.92

2.4

3.0

9.75

10.36

kpa

0.62

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.87

4.92

2.4

3.0

5.07

4.94

kpa

0.23

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

221

1630

1.39

4.87

12.1

11.1

15.33

15.96

2.72

212

1573

(3019150) Specific gravity of Urine by Refractometry

719

6175

1.22

4.85

5.8

4.2

1.02

1.26

kg/l

0.50

568

4140

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

173

1225

1.44

4.81

3.5

2.5

7.47

7.37

g/l

0.28

168

1128

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

173

1225

1.44

4.81

3.5

2.5

3.56

3.71

g/l

0.54

168

1129

(3020393) Adenovirus Ag [Presence] in Stool

5.73

4.75

1.3

1.6

—

(3044007) Cell count panel - Peritoneal fluid

2.68

4.74

1.1

1.9

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.43

4.74

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

3.12

4.63

2.3

2.9

154.11

1895.62

u/l

0.95

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

122

812

1.52

4.63

1.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

14.03

4.57

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

297

1.87

4.56

1.1

—

(40768797) Stomach Pathology biopsy report

487

4047

1.24

4.47

1.4

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

388

1.74

4.44

1.1

116.20

115.74

0.04

350

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.57

4.38

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.57

4.38

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.57

4.38

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.57

4.38

1.0

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

521

1.63

4.33

1.2

1.3

612.00

447.56

titre

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

138

2.26

4.31

1.5

1.7

2.36

3.67

u/field

0.42

100

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.60

4.30

1.0

1.4

13.85

13.75

g/l

0.02

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.27

4.29

3.7

4.4

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

5.52

4.28

1.4

1.8

55.50

62.69

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1861

17516

1.17

4.11

4.9

3.4

82.36

49.34

u/l

12.59

1768

16418

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

4.01

4.09

1.2

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

130

901

1.46

4.09

1.4

253.00

275.66

ug/g

0.63

521

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

251

1.89

4.07

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

167

1216

1.40

4.02

1.5

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

962

0.58

4.00

1.8

7.24

4.48

mg/l

0.58

713

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

588

1.57

3.99

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.48

3.96

1.3

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

146

1044

1.42

3.90

3.4

2.6

9.76

10.29

g/l

0.56

140

938

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

357

0.33

3.90

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

633

0.50

3.86

1.4

1.6

1428.35

990.85

mu/l

0.75

507

(40763480) Human metapneumovirus Ag [Presence] in Specimen

7.29

3.86

2.6

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

307

1.77

3.85

2.0

2.2

—

(3004451) EKG impression Narrative

180

2.01

3.78

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

103

693

1.50

3.77

1.2

1.3

158.34

215.54

miu/ml

0.78

309

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

8.77

3.77

2.9

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

471

3974

1.22

3.73

1.5

1.4

689.91

523.29

titre

0.95

113

888

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.51

3.71

1.0

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1646

15425

1.16

3.59

3.5

2.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

241

1.84

3.57

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

192

1.94

3.53

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

138

2.11

3.49

1.6

1.7

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

317

1.72

3.48

1.4

1.9

—

1640.00

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

426

5026

0.82

3.46

1.3

27.44

11.00

u/ml

2.26

160

1942

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.48

3.46

1.2

6.31

11.48

pmol/l

—

(3010838) Calcium [Moles/time] in 24 hour Urine

530

1.54

3.41

1.8

2.0

5.03

5.06

mmol/24h

0.02

463

(3045414) Leukocytes [Presence] in Urine

331

2717

1.25

3.40

2.8

2.2

0.05

0.01

estimate

0.54

551

(3039000) Anion gap in Blood by calculation

548

1.53

3.36

13.7

8.7

10.70

11.38

mmol/l

1.01

491

(3018572) Chloride [Moles/volume] in Blood

549

1.53

3.33

13.7

8.7

105.84

105.11

mmol/l

0.67

492

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

190

1.91

3.29

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.34

3.22

2.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.34

3.22

2.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.34

3.22

2.2

1.1

—

(3019225) pH of Specimen

328

2708

1.24

3.20

8.4

4.4

7.38

7.35

2.24

295

1929

(4146454) Self-monitoring of blood glucose

336

0.38

3.19

1.5

2.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

301

0.36

3.07

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

466

5391

0.84

3.04

1.3

48.29

32.96

iu/ml

0.83

156

1659

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

639

7202

0.86

3.04

5.9

5.7

4.89

2.67

ug/l

1.94

560

6495

(3013139) Helicobacter pylori Ag [Presence] in Stool

149

1961

0.75

3.04

1.2

1.3

—

(4195642) Thrombophilia screening test

385

1.60

3.03

1.2

—

(3014891) Appearance of Pleural fluid

3.34

3.01

1.3

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

311

0.38

2.98

1.5

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

107

2.16

2.96

1.0

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

2716

27564

0.76

2.95

68.2

25.4

122.09

134.67

g/l

286.30

2699

27290

(3010813) Leukocytes [#/volume] in Blood

2716

27562

0.77

2.92

67.9

25.3

5.98

6.69

e9/l

37.07

2682

26954

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.38

2.89

1.1

1.5

77.27

88.48

0.55

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.10

2.88

1.0

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2716

27559

0.77

2.88

68.3

25.8

36.98

40.25

209.24

2698

27269

(3026361) Erythrocytes [#/volume] in Blood

2716

27559

0.77

2.88

67.8

25.3

4.05

4.47

e12/l

233.45

2683

26952

(3035941) MCH [Entitic mass]

2716

27558

0.77

2.86

67.5

25.2

30.50

30.34

4.41

2698

27280

(36660697) Celiac disease serology panel - Serum

171

2188

0.77

2.86

1.1

1.2

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2716

27555

0.77

2.82

67.6

25.2

92.20

91.25

20.66

2698

27278

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.35

2.81

1.1

1.2

86.18

87.50

0.07

(3007461) Platelets [#/volume] in Blood

2716

27553

0.77

2.80

68.0

25.3

226.12

252.79

e9/l

59.81

2689

27033

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.45

2.79

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.55

2.78

1.5

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

221

1777

1.26

2.75

3.6

4.46

pmol/l

0.01

200

1586

(4027681) Cerebrospinal fluid IgG ratio and IgG index

145

1.94

2.75

1.4

1.2

0.53

ratio

0.02

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

3.24

2.72

1.1

72.83

46.07

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

6.01

2.70

1.0

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

174

2202

0.78

2.68

1.6

1.5

—

(1761868) Lipid panel - Serum or Plasma

901

9834

0.88

2.67

3.2

—

(3002619) Bacteria identified in Specimen by Culture

2.47

2.62

1.1

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

102

740

1.39

2.61

2.0

1.7

416.68

308.59

mu/l

1.25

673

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.16

2.60

1.2

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

598

5311

1.16

2.60

3.7

3.9

322.45

592.13

ng/l

0.62

485

4106

(3051387) C reactive protein [Mass/volume] in Capillary blood

540

1.46

2.59

3.4

3.9

31.76

25.99

mg/l

0.72

362

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

192

1.78

2.58

1.1

567.32

269.24

mg/l

0.65

169

(3001019) Free T4 and TSH panel - Serum or Plasma

1257

0.71

2.58

1.6

1.7

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

323

1.59

2.55

2.0

1.6

62.15

60.32

0.12

198

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.51

2.53

4.4

3.0

5.93

4.78

ug/l

0.33

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

404

1.52

2.51

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

263

2180

1.23

2.51

2.3

2.4

7.22

7.46

ug/l

0.08

232

1962

(3023420) DNA double strand Ab [Units/volume] in Serum

157

1226

1.30

2.49

2.4

1.8

8.39

7.52

iu/ml

0.15

298

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.47

2.48

5.3

2.1

—

(3016750) Collection duration of Urine

158

1.84

2.48

2.4

2.1

504.12

491.54

min

0.27

117

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

4.38

2.47

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.82

2.46

1.4

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

364

0.49

2.44

2.2

1.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.09

2.42

1.5

1.4

357.00

427.94

nmol/24h

0.07

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

200

1.71

2.28

1.1

144.38

38.74

mg/l

0.70

169

(3032057) Clostridioides difficile [Presence] in Stool

2.46

2.27

2.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

415

1.48

2.25

1.3

1.2

1.64

3.75

u/ml

1.53

142

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

268

2254

1.21

2.24

4.1

4.0

101.87

88.55

ng/l

0.99

239

1946

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

173

2136

0.80

2.21

1.8

2.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

211

1.67

2.16

1.4

1.5

13.53

12.23

umol/l

0.50

198

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2539

24861

1.17

2.13

43.3

16.1

80.97

80.11

ml/min/173m2

1.30

2461

23122

(3003329) Lymphocytes/Leukocytes in Synovial fluid

251

1.60

2.12

2.0

1.5

37.02

32.08

0.29

150

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

146

1.79

2.06

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.64

2.00

1.7

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.34

1.96

1.0

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

149

1.75

1.94

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

105

1352

0.77

1.92

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

2.06

1.90

1.5

2.0

0.52

1.20

ug/l

2.08

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

300

1.51

1.87

1.2

1.1

94.00

95.45

0.13

282

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

213

1.60

1.85

1.2

300.00

126.58

titre

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.53

1.83

1.0

1.6

59.07

35.83

nmol/l

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.17

1.82

6.0

4.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

108

1.86

1.81

3.2

2.4

0.60

0.62

mmol/l

0.42

108

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.76

1.79

1.0

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

109

1.84

1.77

1.1

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.92

1.72

11.0

4.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

117

930

1.27

1.70

1.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

126

1.75

1.68

1.1

2.2

162.36

157.96

0.08

121

(4212803) Bone marrow aspirate examination

2.80

1.65

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

149

1801

0.82

1.62

1.2

1.3

23.83

52.04

au/ml

—

136

(44806420) Estimation of glomerular filtration rate

303

1.46

1.61

2.3

2.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

134

0.37

1.60

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

424

0.63

1.59

1.5

1.8

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

107

1.78

1.54

1.2

1.4

2.36

4.36

umol/l

2.64

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

159

0.44

1.54

1.3

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

259

0.54

1.54

2.0

1.7

—

(3044009) aPTT.lupus sensitive (LA screen)

2.60

1.51

1.0

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

165

1959

0.83

1.51

2.2

2.5

24.34

21.68

au/ml

0.09

197

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.90

1.49

1.1

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

496

1.34

1.48

1.2

1.3

120.22

37.36

u/l

2.48

427

(3019174) dRVVT (LA screen)

2.50

1.45

1.0

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

2.50

1.45

1.4

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.73

1.43

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

270

1.45

1.41

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.86

1.40

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

713

1.27

1.40

1.1

5.13

4.42

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.18

1.40

1.3

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.94

1.38

2.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

408

1.35

1.36

1.2

3.04

4.57

u/ml

0.92

175

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

165

1938

0.84

1.36

1.7

1.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.83

1.35

2.1

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

315

1.40

1.35

6.1

2.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

209

0.52

1.34

1.4

1.5

56.60

55.62

ug/l

0.05

209

(3014051) Protein [Presence] in Urine by Test strip

710

7597

0.91

1.32

4.1

3.0

0.25

0.03

—

168

(3004775) Volume in Urine collected for unspecified duration

208

1.50

1.32

2.4

2.2

786.42

637.42

1.19

141

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

557

0.71

1.32

4.3

2.0

1.10

0.85

nmol/l

1.03

465

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

440

0.68

1.32

1.0

1.1

25.83

1459.07

iu/ml

—

(3045424) Erythrocytes [Presence] in Urine

163

1386

1.19

1.31

3.2

2.2

0.02

0.60

estimate

0.49

426

(4094501) Cardiovascular stress test using bicycle ergometer

806

0.76

1.31

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.78

1.28

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

305

0.62

1.27

1.3

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.09

1.27

3.4

2.4

15.75

18.36

umol/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.00

1.27

1.5

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.29

1.26

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.05

1.26

1.0

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

132

1.60

1.20

1.9

1.4

3.50

4.33

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.75

1.19

1.3

1.0

—

(3020650) Glucose [Presence] in Urine

1.73

1.15

1.3

1.8

0.00

0.07

estimate

0.80

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

210

0.57

1.14

1.6

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

532

1.27

1.08

3.1

3.5

0.98

0.81

nmol/l

0.91

437

(3003888) Timothy IgE Ab [Units/volume] in Serum

408

0.71

1.06

1.1

3.67

3.64

u/ml

0.00

210

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

105

1.62

1.06

1.4

2.6

16.34

94.20

ug/l

0.52

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.12

1.05

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

178

1.46

1.05

2.2

1.4

98.19

81.79

umol/l

0.47

178

(3008401) Mugwort IgE Ab [Units/volume] in Serum

395

0.71

1.05

1.1

0.90

1.52

u/ml

0.40

167

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1063

0.82

1.04

1.6

32.37

15.32

u/ml

0.57

224

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

187

1.45

1.03

1.0

1.1

—

(3001729) Color of Synovial fluid

2.27

1.03

1.2

1.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.27

1.03

1.0

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.18

0.98

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.18

0.98

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.67

0.97

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

1.9

—

46.37

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.95

0.97

1.0

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.63

0.97

1.1

2.4

193.73

173.03

0.31

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

489

0.75

0.94

1.1

4.67

1.74

u/ml

0.40

274

(3000330) Specific gravity of Urine by Test strip

154

1346

1.15

0.94

4.6

3.4

1.02

ratio

0.04

149

1230

(4268621) Lupus anticoagulant assay

294

1.33

0.94

2.2

2.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

419

1.27

0.91

1.3

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

420

1.27

0.90

1.3

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2025

20644

0.94

0.89

5.1

4.6

15.01

14.81

pmol/l

3.13

1888

19016

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.00

0.87

1.2

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

136

1.47

0.86

1.0

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

233

2107

1.12

0.85

3.0

153.48

181.14

ng/l

0.68

216

1917

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

344

0.72

0.85

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

300

1.30

0.84

1.6

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

292

1.31

0.83

3.3

3.9

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.74

0.82

11.8

12.4

4.90

5.58

mmol/l

—

(4198724) Urine methamphetamine measurement

1.61

0.81

2.8

1.9

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

793

1.18

0.81

1.9

2.0

3.83

11.70

iu/l

0.55

318

(3048689) Calprotectin [Mass/mass] in Stool

377

3504

1.09

0.80

3.4

2.3

224.52

135.16

ug/g

2.83

315

2798

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.62

0.78

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.77

0.76

1.0

2.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.77

0.76

1.0

1.1

0.32

0.02

u/ml

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

386

1.25

0.75

1.4

1.3

717.29

321.22

pmol/l

0.81

329

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.57

0.75

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.09

0.74

1.6

2.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.09

0.74

1.2

1.3

1.80

14.75

u/l

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

210

1.34

0.73

1.8

2.1

1.47

1.67

u/field

0.19

118

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

108

1.48

0.73

1.6

2.4

79.13

143.39

umol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

211

2317

0.90

0.73

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

291

1.27

0.71

1.2

1.4

1.65

1.51

nmol/l

0.33

266

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.71

0.70

1.0

1.2

—

(3017704) Immunofixation for Urine

169

1.36

0.69

2.4

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

598

6277

0.94

0.68

1.3

1.00

1.56

u/ml

1.16

178

1687

(3027035) Albumin [Mass/time] in 24 hour Urine

1.79

0.66

1.8

1.3

—

640.53

—

(4034850) Laboratory test

809

0.85

0.66

12.6

10.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.54

0.65

1.0

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1195

12293

0.95

0.65

2.1

91.36

96.84

pmol/l

3.87

759

6357

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

774

1.15

0.64

1.1

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

189

1.33

0.64

3.2

1.8

126.74

108.26

ng/l

0.43

189

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

279

0.75

0.61

3.1

5.2

136.97

54.94

u/ml

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.67

0.61

1.0

1.1

102.40

84.27

titre

—

(3005322) IgE [Units/volume] in Serum or Plasma

203

1865

1.10

0.60

1.3

281.70

203.12

u/ml

0.36

174

1726

(3000034) Microalbumin [Mass/volume] in Urine

227

1.28

0.60

3.5

2.9

56.24

29.93

mg/l

0.56

162

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.54

0.59

1.1

1.0

54.78

40.29

iu/ml

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

344

0.78

0.59

2.8

2.3

36.64

21.64

mg/l

0.59

125

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

288

0.76

0.59

1.0

0.21

0.24

u/ml

—

101

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

132

1.37

0.57

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

310

1.23

0.57

3.1

1.5

—

(44806071) Cardiolipin IgM antibody measurement

1.67

0.56

1.3

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.67

0.56

1.2

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

308

0.78

0.56

1.4

1.3

8.97

7.40

mmol/l

1.20

268

(3035320) C reactive protein [Mass/volume] in Body fluid

203

1.28

0.55

2.7

32.39

31.12

mg/l

0.05

145

(3008898) HLA-B27 [Presence]

900

0.87

0.55

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

197

1818

1.09

0.54

2.5

2.3

11.43

13.06

nmol/l

1.77

180

1634

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.58

0.54

1.2

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.54

0.53

1.0

1.1

—

(4024509) Urine culture

147

1341

1.10

0.52

2.5

2.0

—

(40768443) Skin Pathology biopsy report

138

1256

1.10

0.52

1.2

—

(3022621) pH of Urine by Test strip

228

2125

1.08

0.51

3.1

2.7

6.07

0.02

183

1442

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

687

1.14

0.51

1.2

7.88

3.91

u/ml

—

(40768800) Prostate Pathology biopsy report

485

0.84

0.48

1.1

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.49

0.47

1.9

2.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

129

1408

0.91

0.45

2.1

2.4

—

(4211845) Urine protein measurement

128

0.70

0.43

2.2

3.2

—

(3022689) Creatine [Moles/volume] in Urine

0.64

0.42

1.7

1.4

5.39

7.71

mmol/l

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

158

1.27

0.41

1.1

1.23

1.12

u/l

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.41

0.0

1.2

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

10.22

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

277

1.19

0.41

1.4

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

78.18

—

(3014271) Vancomycin [Susceptibility]

114

1.32

0.40

2.4

2.9

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

168

1.25

0.40

1.4

21.39

22.92

umol/l

0.09

152

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.43

0.39

1.0

1.1

—

(3003129) Base excess in Capillary blood by calculation

344

1.17

0.38

2.7

2.4

0.44

0.41

mmol/l

0.01

333

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

169

1.24

0.38

2.1

1.5

7.39

6.46

u/l

0.18

148

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

107

981

1.09

0.38

1.6

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

457

1.14

0.38

1.0

1.1

7.22

19.03

au/ml

—

100

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

224

1.21

0.38

1.4

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

333

3182

1.05

0.38

17.1

6.7

—

(3006462) Nitrate [Presence] in Urine

116

0.69

0.37

2.4

3.4

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

244

1.19

0.36

1.4

1.1

—

(3024928) Oxygen saturation in Venous blood

745

1.10

0.36

3.4

3.3

63.10

61.26

0.32

727

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.66

0.35

1.8

1.5

6.50

9.36

ug/l

—

(4015189) Microbial culture of sputum

1.37

0.34

2.5

2.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

759

1.10

0.33

1.7

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

110

1186

0.92

0.33

1.6

1.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

452

4369

1.04

0.33

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

173

1.22

0.32

1.0

1.1

18.28

16.69

u/ml

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.28

0.32

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.28

0.32

1.8

2.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

220

1.18

0.31

1.4

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

0.73

0.30

6.3

2.9

22.57

29.53

umol/l

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2716

27062

1.06

0.30

55.7

21.6

77.98

76.51

umol/l

1.26

2696

26774

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

832

1.08

0.29

1.3

3.74

6.63

u/ml

0.30

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

180

1894

0.95

0.28

1.2

111.12

147.19

u/ml

0.88

718

(3019420) Tryptase [Mass/volume] in Serum or Plasma

162

0.80

0.28

1.7

1.5

12.07

8.41

ug/l

0.31

143

(3011288) Drugs identified in Urine by Screen method Nominal

500

1.10

0.26

3.8

2.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

225

0.84

0.26

1.2

0.53

0.80

u/ml

—

124

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

234

1.16

0.26

1.4

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

234

1.16

0.26

1.4

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

0.70

0.26

1.2

1.1

164.80

283.28

pmol/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

569

1.09

0.25

4.9

2.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.74

0.24

2.0

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

237

1.14

0.23

1.4

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

136

0.81

0.23

1.2

1.3

163.55

164.45

mmol/24h

0.01

136

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

834

1.07

0.23

1.3

16.63

6.51

u/ml

0.57

133

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

229

1.14

0.21

1.4

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.19

0.21

1.0

1.6

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

313.10

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.14

—

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.12

—

(3016879) Cocaine [Presence] in Urine

663

1.07

0.20

4.5

2.1

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.20

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.20

0.0

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

269

1.12

0.19

1.6

1.3

32505.17

84831.59

e6/l

0.71

181

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

133

0.83

0.19

1.3

1.4

157.21

163.37

pmol/l

0.06

133

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

165

1.15

0.19

1.6

1.4

—

(3034426) Prothrombin time (PT)

1.24

0.18

1.1

1.3

30.50

28.55

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

373

0.91

0.18

1.0

1.1

2.71

1.22

u/ml

0.29

191

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

466

0.92

0.18

1.7

1.3

0.14

0.40

nmol/l

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.17

0.17

13.1

8.8

5.96

5.42

kpa

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

681

0.94

0.17

1.1

5.96

5.93

eliau/ml

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

189

1.11

0.13

1.2

1.4

—

66.47

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

128

0.86

0.13

1.1

1.3

—

(44813793) Dust mix specific IgE antibody measurement

180

0.89

0.13

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

117

0.85

0.13

1.0

1.2

9.90

10.30

mm/h

—

117

(3000764) Benzodiazepines [Presence] in Urine

718

1.05

0.12

4.3

2.0

—

(3024263) Appearance of Synovial fluid

133

1.13

0.12

1.6

1.8

—

(3049717) Cytology report of Urine Cyto stain

108

1043

1.04

0.12

3.1

2.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

863

0.96

0.11

1.6

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2693

26884

1.02

0.11

33.5

12.8

26.28

25.78

u/l

0.90

2670

26151

(3028300) Cannabinoids [Presence] in Urine

722

1.04

0.10

4.4

2.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

310

0.93

0.10

1.0

1.1

1.53

3.12

u/ml

1.07

135

(3014133) Dog dander IgE Ab [Units/volume] in Serum

330

0.94

0.09

1.0

1.1

3.72

2.16

u/ml

0.35

156

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.06

0.09

1.6

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

258

0.93

0.09

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

350

0.94

0.09

1.1

2.41

3.38

eliau/ml

0.35

146

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

969

0.97

0.09

1.5

1.8

—

(3033099) Centromere Ab [Titer] in Serum

0.81

0.08

1.2

—

(4133840) Spirometry

0.81

0.08

1.4

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.14

0.08

1.1

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

303

2989

1.02

0.08

1.9

1.8

1.47

1.48

0.11

257

2609

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.08

0.08

1.1

1.3

—

0.31

—

(3027008) Opiates [Presence] in Urine

718

1.03

0.07

4.3

2.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

887

1.03

0.07

1.3

28.41

36.73

u/ml

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

128

1.09

0.06

4.6

1.7

39.42

39.69

g/l

0.06

128

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

183

0.93

0.06

3.1

6.9

3.25

123.02

ug/l

—

111

(3032773) Endomysium IgG Ab [Titer] in Serum

253

0.95

0.05

1.0

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

188

1.06

0.05

1.1

10.77

9.62

iu/ml

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

149

1.07

0.05

1.0

—

(3027944) Amphetamines [Presence] in Urine

713

1.02

0.05

4.4

1.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

386

1.04

0.05

1.0

1.2

—

(3005570) Glucose [Moles/volume] in Urine

262

0.95

0.04

2.2

2.1

—

(3044927) Protein electrophoresis panel - Urine

288

1.04

0.04

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

229

1.05

0.04

1.9

2.0

27.84

6.34

umol/l

0.82

163

(3004616) Nuclear Ab [Presence] in Serum

372

0.97

0.04

1.3

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

131

1.07

0.03

2.0

2.4

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

151

1.06

0.03

1.6

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

132

1.06

0.02

1.5

1.3

7.00

5.94

mmol/l

0.71

124

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

103

1.07

0.02

4.2

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

414

1.01

0.00

1.1

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

159

1.01

0.00

1.1

1.3

120.88

135.79

nmol/l

1.10

159

(3025018) Bordetella pertussis Ab [Titer] in Serum

179

1.01

0.00

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

601

1.00

0.00

5.5

4.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

651

1.00

0.00

1.3

1.2

62.90

47.47

u/ml

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

176

1.02

0.00

1.7

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

624

0.99

0.00

2.9

2.4

151.34

111.32

ug/min

0.41

374

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

398

1.01

0.00

1.7

1.3

0.25

0.23

nmol/l

0.15

313

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

422

1.00

0.00

2.1

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

742

1.00

0.00

2.0

1.7

17065.41

11396.05

e6/l

0.51

516

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.95

-0.00

1.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

8.4

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1308.00

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

8.4

—

74.80

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

108

1080

1.00

-0.00

1.8

1.7

0.33

mg/l

0.00

492

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

6.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.00

-0.00

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

2.07

—

(3036180) Methadone [Presence] in Urine

0.00

-0.00

0.0

3.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.02

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

35.27

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3220.00

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

3.39

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

380

1.00

-0.00

1.8

1.3

—

nmol/l

—

Mortality – FinRegistry

↥

Association

Association between endpoint DRUGADVERS_NEUTROPENIA and mortality.

Females

Parameter	HR [95% CI]	p-value
DRUGADVERS_NEUTROPENIA	8.726 [7.5, 10.15]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.057

During the follow-up period (1.1.1998 — 31.12.2019), 2730 out of 6944 females with DRUGADVERS_NEUTROPENIA died.

Males

Parameter	HR [95% CI]	p-value
DRUGADVERS_NEUTROPENIA	9.331 [7.49, 11.63]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 2303 out of 4090 males with DRUGADVERS_NEUTROPENIA died.

Mortality risk

Mortality risk for people of age

years, who have DRUGADVERS_NEUTROPENIA.

N-year risk	Females	Males
1	0.721%	1.851%
5	4.66%	10.622%
10	11.24%	23.446%
15	20.101%	40.366%
20	32.103%	60.541%

Relationships between endpoints

↥

Index endpoint: DRUGADVERS_NEUTROPENIA – Drug-induced neutropenia

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Drug-induced neutropenia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints